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ARTICLE
Impaired mitophagy links mitochondrial disease
to epithelial stress in methylmalonyl-CoA
mutase deﬁciency
Alessandro Luciani1,11✉, Anke Schumann1,2,11, Marine Berquez1,11, Zhiyong Chen 1,11, Daniela Nieri1,
Mario Failli3, Huguette Debaix1, Beatrice Paola Festa1, Natsuko Tokonami1, Andrea Raimondi 4,
Alessio Cremonesi5, Diego Carrella6, Patrick Forny 2, Stefan Kölker7, Francesca Diomedi Camassei8,
Francisca Diaz9, Carlos T. Moraes9, Diego Di Bernardo 6, Matthias R. Baumgartner 2 &
Olivier Devuyst 1,10✉
Deregulation of mitochondrial network in terminally differentiated cells contributes to a broad
spectrum of disorders. Methylmalonic acidemia (MMA) is one of the most common inherited
metabolic disorders, due to deﬁciency of the mitochondrial methylmalonyl-coenzyme A
mutase (MMUT). How MMUT deﬁciency triggers cell damage remains unknown, preventing
the development of disease–modifying therapies. Here we combine genetic and pharmaco-
logical approaches to demonstrate that MMUT deﬁciency induces metabolic and mito-
chondrial alterations that are exacerbated by anomalies in PINK1/Parkin–mediated
mitophagy, causing the accumulation of dysfunctional mitochondria that trigger epithelial
stress and ultimately cell damage. Using drug–disease network perturbation modelling, we
predict targetable pathways, whose modulation repairs mitochondrial dysfunctions in
patient–derived cells and alleviate phenotype changes in mmut–deﬁcient zebraﬁsh. These
results suggest a link between primary MMUT deﬁciency, diseased mitochondria, mitophagy
dysfunction and epithelial stress, and provide potential therapeutic perspectives for MMA.
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M itochondria—the intracellular powerhouse in whichenergy from nutrients is converted into ATP—arehighly dynamic, double-membraned organelles that
sustain cellular metabolism and physiology1,2. The maintenance
of these dynamic and functionally pleiotropic organelles is par-
ticularly relevant in terminally differentiated cells that are highly
dependent on aerobic metabolism3. Genetic dysfunctions of the
mitochondrial network and homeostasis might therefore confer a
potentially devastating vulnerability to many different cells con-
tributing to a broad spectrum of diseases4.
Mitochondrial diseases are among the most common type of
inherited metabolic disorders, which often manifest in early
childhood and are associated with high morbidity and
mortality5,6. Methylmalonic acidaemia (MMA; MIM #251000)—
the most common form of organic aciduria7,8—is caused by
recessive, inactivating mutations in theMMUT gene encoding the
mitochondrial enzyme methylmalonyl-coenzyme A mutase
(MMUT) that mediates the terminal step of branched-chain
amino acid metabolism9. Complete (mmut0) and/or partial
(mmut–) loss of MMUT function results in the accumulation of
toxic metabolites (e.g. methylmalonic acid [MMA], propionic
acid and 2-methylcitric acid) within mitochondrial matrix that
trigger ultrastructural (e.g. presence of megamitochondria with
abnormal cristae; ref. 10) and/or functional (e.g. abnormal mito-
chondrial energetic and redox proﬁling) mitochondrial
alterations10,11, causing severe organ dysfunctions that primarily
affect brain, liver and kidney12,13. The mechanisms linking
MMUT deﬁciency to mitochondrial dysfunctions and cell toxicity
remain largely unknown, restricting therapeutic avenues for this
devastating disorder to supportive care14.
The epithelial cells that line kidney tubules are enriched in
mitochondria, whose energy production maintains transport
functions and overall kidney integrity15. Disruption of mito-
chondrial homeostasis in inherited mitochondrial cytopathies
drives various degrees of epithelial (tubular) dysfunction and
kidney disease16. For instance, a systematic study of 42 patients
with mitochondrial disorders showed that 21 patients had kidney
tubular dysfunction and 8 had renal failure, conﬁrming the
underestimated prevalence of kidney involvement in these dis-
orders17. Conversely, modulating mitochondrial function might
restore kidney function in mouse models of acute18 and chronic
kidney disease19.
Cells possess quality control systems to maintain a requisite
number of functional mitochondria to meet the energy
demands20. These pathways concur to eliminate damaged mito-
chondrial proteins or dysfunctional parts of mitochondrial net-
work by autophagy (aptly termed mitophagy; ref. 21). Biochemical
and genetic evidences reveal that the PTEN-induced putative
kinase1 (PINK1) and Parkin are the key drivers of mitophagy,
driven by the loss of mitochondrial membrane potential22. This
homoeostatic mitochondrial process is particularly active in
kidney tubular cells23. Deletion of genes encoding mitophagy-
promoting molecules damages tubular cells through defective
mitochondrial clearance and increased reactive oxygen species
(ROS)24. Abnormal mitochondria with disorganized cristae have
been described in kidney cells25 and biopsies from MMA
patients10,26, suggesting an involvement of mitochondrial quality
control mechanisms in the disease.
In the present study, using MMA as a paradigm of complex
mitochondrial dysfunction, we decipher a pathway that links
loss-of-function of a mitochondrial enzyme, mitochondrial
abnormalities, defective PINK1/Parkin-mediated quality con-
trol and mitochondria-derived stress in kidney tubular cells.
These insights offer promising therapeutic avenues for mod-
ulating mitochondrial function and epithelial cell damage
in MMA.
Results
MMUT deﬁciency impairs mitochondria in kidney tubular
cells. As MMUT is robustly expressed within the mitochondria of
kidney tubular cells (Supplementary Fig. 1a‒e), we ﬁrst investi-
gated the consequences of MMUT deﬁciency on mitochondrial
function and homeostasis in these cells. To this aim, we analysed
the properties of mitochondrial network in kidney tubular cells
derived from the urine of either healthy controls or mut0 MMA
patients harbouring inactivating mutations in MMUT (Supple-
mentary Table 1; ref. 25). Compared to their control cells, the
MMA patient-derived kidney tubular cells (hereafter referred to
as MMA cells) exhibited a marked decrease in MMUT protein
(Fig. 1a) and in its mitochondrial enzymatic activity (Fig. 1b, c),
reﬂected by the accumulation of methylmalonic acid (MMA;
Fig. 1d). Transmission electron microscopy (TEM) analyses
revealed that mitochondria, which appear as an interconnected
meshwork of elongated or curvilinear organelles in control cells,
were fragmented or characterized by a prominent rod-like shape
with perturbed cristae organization in MMA cells (Fig. 1e) and in
the kidneys of a patient with MMA (Fig. 1f), in line with recent
studies showing an abnormal mitochondrial ultrastructure in
both kidney and explanted livers of patients with MMA26. Con-
focal microscopy of the mitochondrially targeted green ﬂuor-
escent protein (mito-GFP) and semi-automated image analyses
conﬁrmed in MMA cells the presence of mitochondria which
appear circular and robustly fragmented when compared to
control cells (Fig. 1g).
The morphological abnormalities prompted us to examine
whether MMUT deﬁciency alters the homeostasis of the
mitochondrial network. Using immunoblotting analyses for
mitochondrial proteins that label outer (e.g. VDAC1) and inner
membrane (e.g. SDH, MT-CO2 and COX IV), intermembrane
space (e.g. Cyt C) and matrix (e.g. PDHA1), we noted an
increased abundance of overall mitochondrial proteins in MMA
compared to control cells (Fig. 2a). These changes were
conﬁrmed by measuring the ratio between mitochondrial (mt-
DNA) and nuclear (n-DNA) through quantitative PCR analyses
(Fig. 2b) and by quantifying the ATP5B-ﬂagged mitochondrial
structures using confocal microscopy (Fig. 2c). These mitochon-
drial alterations did not result from an effect ofMMUT deﬁciency
on cell viability (Supplementary Fig. 1f) and proliferation
(Supplementary Fig. 1g), nor transcriptional changes in mito-
chondrial genes (MFN1/2, DRP1, OPA1) regulating fusion/ﬁssion
process (Supplementary Fig. 1h), which were similar between
MMA and control cells. Taken together, these data indicate that
the deﬁciency of MMUT alters the homeostasis of the
mitochondrial network, hence increasing the content of mito-
chondria organelles.
Mitochondrial dysfunction drives stress in MMA cells. As
MMUT deﬁciency alters mitochondrial homeostasis, we next
assessed potential consequences on mitochondrial function.
Consistent with increased numbers of morphologically aberrant
mitochondria, the mitochondrial membrane potential (Δψm) was
drastically reduced in MMA cells (Fig. 2d), as evidenced by live
cell imaging analyses of the mitochondrial network with cell-
permeant, ﬂuorescent dye tetramethylrhodamine methyl ester
(TMRM, which readily accumulates within functional mito-
chondria) and MitoTracker (a ﬂuorescent probe that localizes to
mitochondria). These changes were paralleled by a major mito-
chondrial oxidative stress (Fig. 2e), as testiﬁed by the elevated
production of mitochondria (mt)-derived ROS (MitoSOX, a live-
cell-permeant indicator of mitochondrial ROS) and augmented
antioxidant response (SOD1; Fig. 2g). Treatment with the mito-
chondrial complex I inhibitor Rotenone (5 μM for 24 h), which
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did not alter the cell viability, exacerbated mitochondrial altera-
tions (e.g. decreased mitochondrial membrane potential and
increased mt-ROS levels) to a greater extent in MMA compared
to control cells (Fig. 2d, e). Seahorse metabolic ﬂux analyses
measuring oxygen consumption rate (OCR) conﬁrmed impaired
mitochondrial bioenergetics in MMUT-deﬁcient cells, as evi-
denced by a signiﬁcant reduction in the baseline respiration, ATP
turnover and total respiratory capacity (Fig. 2f), suggesting that
MMUT deﬁciency impinges on the function and homeostasis of
mitochondrial network in both normal and stress-evoked
conditions.
Previous studies in transgenic Mmut-deﬁcient mice and in a
large cohort of patients with MMA10,26 showed that mitochon-
drial dysfunction and oxidative stress are linked to increased
production of lipocalin-2 (LCN2, also known as NGAL), a small
iron-transporting protein largely produced by kidney tubular cells
following cellular damage27. In line with these observations, we
noticed an increase in LCN2 mRNA and protein expression in
MMA compared to control cells (Fig. 2g; Supplementary Fig. 1i).
The link between compromised mitochondria, oxidative stress
and LCN2 overproduction was substantiated by loss-of-function
interventions in primary proximal tubule (PT) cells derived from
wild-type mouse kidneys28. Short-hairpin (sh) RNA-induced
knockdown of Atg7 encoding an essential protein necessary for
autophagy causes mitochondrial dysfunction and mitochondrial
oxidative stress with increased production of Lcn2 in these cells
(Supplementary Fig. 2a–e). These data indicate a functional link
between mitochondrial dysfunction, oxidative stress and LCN2
overproduction, hence the existence of mitochondria-derived
epithelial stress in kidney tubular cells.
MMUT-deﬁcient phenotypes in model organisms. To explore
the consequences of theMMUT deﬁciency in vivo, we investigated
a Mmut KO/KI mouse model carrying a mutant Mmut allele (p.
Met698Lys, corresponding to the patient mutation p.Met700Lys)
and a knockout Mmut allele29. The loss of Mmut was reﬂected by
the accumulation of MMA (Supplementary Fig. 3a) and distorted
kidney mitochondria which appear rod-like shape with impaired
cristae organization (Supplementary Fig. 3b). Consistent with
morphologically aberrant mitochondria, the membrane potential
(Δψm) was drastically reduced in MMA-accumulating kidney
PT cells derived from MmutKO/KI mice (TMRM staining; Sup-
plementary Fig. 3c). These changes were paralleled by a major
mitochondrial oxidative stress, as testiﬁed by elevated mt-ROS
levels (MitoSOX staining; Supplementary Fig. 3d). Despite the
metabolic and/or mitochondrial alterations (Supplementary
Fig. 3a, d), MmutKO/KI mice displayed mildly increased levels of
urea (Supplementary Fig. 3e); no signiﬁcant changes in kidney
function (plasma levels and clearance of creatinine; Supplemen-
tary Fig. 3f, g); no changes in Lcn2 levels in kidneys as well as in
plasma and/or urine—even in aged mutant mice (Supplementary
a
Control MMA
MMUT
β-actin
75
37
MW
(kDa)
0
0.5
1.0
2.0
1.5
*
M
M
UT
/β-
a
ct
in
1
10
100
1000
10,000
100,000
M
M
UT
 a
ct
ivi
ty
pm
ol
/m
in
/m
g 
pr
ot
ei
n
*
b c
Co
nt
ro
l
M
M
A
Mitochondria MMUT Merge
0
50
100
150
***
d
e
Control Patient
f g
+Ad-mito-GFP
***
#
Control
MMA
Control
MMA
Control
MMA
Co
nt
ro
l
M
M
A
0
0.2
0.4
0.6
0.8
1.0
0
0.2
0.4
0.6
0.8
1.0
M
ito
ch
on
dr
ia
l s
ha
pe
ci
rc
ul
ar
ity
M
ito
ch
on
dr
ia
l
in
te
rc
on
ne
ct
iv
ity
+Ad-mito-GFP
Control
MMA
M
M
A 
le
ve
ls
 (n
mo
l L
–
1 )
Control MMA
0
0.2
0.4
0.6
0.8
1.0
M
ito
ch
on
dr
ia
l s
ha
pe
ci
rc
ul
ar
ity
#
Control
MMA
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liquid chromatography tandem mass spectrometry (LC-MS/MS, n= 3 biologically independent samples). e Representative electron micrographs and
quantiﬁcation of the shape (expressed as circularity) of the mitochondrial network in control and MMA cells; n= 527 mitochondria pooled from 24 control
cells and n= 310 mitochondria pooled from 20 MMA cells. Values are pooled from two biologically independent experiments. Dotted yellow squares
represent regions of the respective panels magniﬁed. f Representative electron micrographs showing the mitochondrial network in kidney biopsies from an
individual healthy control subject and a patient with MMA. g Representative inverted images (left) and quantiﬁcation of shape (expressed as circularity,
top right) or interconnectivity (bottom right) of the mitochondrial network in control and MMA cells; each point representing the average values for
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Fig. 3h–j); and no structural damage (Supplementary Fig. 3k) nor
interstitial inﬂammation (Supplementary Fig. 3l, m) in the kidneys
compared to control littermates.
As the MmutKO/KI mouse model does not show key features of
kidney disease in MMA, we established the ﬁrst mmut-knockout
zebraﬁsh model using CRISPR/Cas9 genome editing. We
obtained a zebraﬁsh mutant line carrying an 11-bp-CRISPR/
Cas9-induced deletion (mmutdel11/de111), generating a premature
stop codon within exon 3, resulting in a truncated protein
deprived of its catalytic activity (Supplementary Fig. 4a‒c).
Homozygous mmutdel11/del11 zebraﬁsh larvae, which appear
morphologically normal and display no obvious development
defects (Supplementary Fig. 4d), exhibit accumulation of MMA
(Fig. 3a), which was abolished by re-expressing wild-type mmut
cDNA in the liver (Supplementary Fig. 4e), validating the
speciﬁcity of the deletion model. When compared to control
littermates, both the kidney and the liver of mmut-deﬁcient
zebraﬁsh exhibited altered mitochondrial morphology character-
ized by increased mitochondrial circularity (Fig. 3b, c) with
perturbed cristae organization. Seahorse metabolic ﬂux analyses
a
SDH
PDHA1
MT-CO2
VDAC1
COX IV
Cyt C
β-actin
75
50
25
37
20
15
37
Control MMA MW(kDa)
0
2
6
4
Pr
ot
ei
n 
ta
rg
et
s/
β-a
ct
in
*
*
** ***
***
**
Control
MMA
SD
H
PD
HA
1
MT
-CO
2
VD
AC
1
CO
X I
V
Cy
t C
TM
R
M
M
ito
Tr
ac
ke
r
Control MMA
+24 h Rot +24 h Rot
0
0.5
1.0
1.5
TM
R
M
/M
ito
Tr
ac
ke
r
flu
or
es
ce
nc
e 
in
te
ns
ity
 ra
tio
d
#
#
#
#
Control
MMA
– + – +Rot (24 h)
b
1
2
4
3
0
m
t-D
N
A/
n-
DN
A
***
c Control MMA
+24 h Rot +24 h Rot
e
50
100
150
200
0
AT
P5
B+
 
st
ru
ct
ur
es
n
u
m
be
r p
er
 c
el
l
Co
nt
ro
l
M
M
A
ATP5B/DAPI
1
2
3
4
0
M
ito
SO
X/
M
ito
Tr
ac
ke
r
flu
or
es
ce
nc
e 
in
te
ns
ity
 ra
tio # #
***
NS
M
ito
SO
X
M
ito
Tr
ac
ke
r
#
Control
MMA
Control
MMA
Control
MMA
– + – +Rot (24 h)
500
1000
1500
2000
0
600
900
1200
2000
300
0O
CR
 (p
mo
l/m
in/
10
4  
ce
lls
)
Basal 
respiration
Maximal
respiration
ATP
production
6040200 80
***
*
**
f g
1
2
3
0
SO
D1
LC
N2
***
*
Pr
ot
ei
n 
ta
rg
et
s/
β-a
ct
in
Control
MMA
Control
MMA
Oligo FCCP Rot+Ant
20
15
20
37
SOD1
LCN2
β-actin
MW
(kDa)Control MMA
Time (min)
Control
MMA
O
CR
 (p
mo
l/m
in/
10
4  
ce
lls
)
Fig. 2 Mitochondrial dysfunctions in MMA kidney cells. a Representative immunoblotting and quantiﬁcation of the indicated mitochondrial proteins; n= 5
biologically independent experiments. b The ratio between mitochondrial DNA (ND1) and nuclear DNA (ACTB) was determined by quantitative PCR; n= 4
biologically independent experiments. c Cells were immunostained for ATP5B (red) and imaged by confocal microscopy. Representative images and
quantiﬁcation of numbers of ATP5B+ structures per cell (n= 27 control cells and n= 40 MMA cells pooled from three biologically independent
experiments). Nuclei counterstained with DAPI (blue). d, e Cells were exposed to mitochondrial complex I inhibitor Rotenone (Rot, 5 μM). After 24 h of
treatment, the cells were loaded (d) with tetramethylrhodamine methyl ester (TMRM; green; mitochondrial membrane potential ﬂuorescent probe, 50 nM
for 30min at 37 °C) and MitoTracker (red; ﬂuorescent probe that localizes to mitochondria; 1 μM for 30min at 37 °C) or (e) with MitoSOX (green;
mitochondrial ROS indicator, 2.5 μM for 25min at 37 °C) and MitoTracker (red), and analysed by confocal microscopy. Representative images and
quantiﬁcation of d membrane potential and e mitochondrial ROS (both calculated as ratio between TMRM and MitoTracker or MitoSOX and MitoTracker
ﬂuorescence intensities, with each point representing the average ﬂuorescence intensity ratio in a cell). TMRM/MitoTracker: n= 21 untreated and Rot-
treated control cells, n= 22 untreated MMA cells and n= 18 Rot-treated MMA cells. MitoSOX/MitoTracker: n= 31 untreated control cells and n= 40
Rot-treated control cells n= 36 untreated MMA cells and n= 31 Rot-treated MMA cells. Values are pooled from three biologically independent
experiments. f Oxygen consumption rate (OCR) and individual parameters for basal respiration, ATP production and maximal respiration. OCRs were
measured at baseline and after the sequential addition of Oligomycin (Oligo, 1 μM), FCCP (0.5 μM) and Rotenone (Rot; 1 μM)+Antimycin A (Ant; 1 μM),
n= 3 biologically independent experiments. g Immunoblotting and quantiﬁcation of the indicated proteins; n= 3 biologically independent experiments.
Plots represent mean ± SEM. Two-tailed Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001 and #P < 0.0001 relative to untreated or to Rot-treated control
cells or to untreated MMA cells. β-actin was used as a loading control in a and b. Scale bars, 10 μM. NS non-signiﬁcant. Source data are provided as a
Source Data ﬁle.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14729-8
4 NATURE COMMUNICATIONS |          (2020) 11:970 | https://doi.org/10.1038/s41467-020-14729-8 | www.nature.com/naturecommunications
revealed impaired mitochondrial bioenergetics in mmut-deﬁcient
zebraﬁsh when compared to control larvae (Fig. 3d). These
changes were paralleled by a major mitochondrial oxidative
stress, as testiﬁed by in vivo imaging and ratiometric light-
sheet microscopy-based analyses of glutathione redox ﬂuorescent
signals in liver Grx1-roGFP2-labelled mitochondria (Fig. 3e),
demonstrating the evolutionary conservation of this connection.
Furthermore, mmut-deﬁcient zebraﬁsh larvae markedly swim
over shorter distances (Fig. 3f; Supplementary Fig. 3f) and show
an excessive mortality (Fig. 3g) compared to control larvae. Both
traits were rescued by feeding mmut-deﬁcient zebraﬁsh larvae
(Fig. 3f, g) with low-protein diet—a strategy used in the MMA
management care12. Re-expressing wild-type mmut cDNA in the
liver of mmut-deﬁcient zebraﬁsh larvae, which normalized the
levels of MMA metabolite and blunted the excessive mortality
(Fig. 3g; Supplementary Fig. 4e), did not rescue the abnormal
swimming phenotype (Supplementary Fig. 4g). Collectively, these
results demonstrate that MMUT deﬁciency compromises the
function and the homeostasis of mitochondrial network, both
in vitro and in vivo.
MMUT deﬁciency induces autophagy. As damaged mitochon-
dria are normally removed by autophagy–lysosome pathways30,
we hypothesized that mitochondrial abnormalities in MMA cells
might reﬂect changes in autophagy–lysosome degradation sys-
tems. We measured autophagy by detecting the conversion of the
non-lipidated form of LC3-I to the lipidated, autophagosome-
associated form LC3-II through immunoblotting and/or by
quantifying the numbers of punctate LC3+ vesicles through
confocal microscopy and/or the abundance of electron micro-
scopy (EM) structures compatible with autophagic vacuoles
(AVs)31. Compared to control cells, we detected in MMA cells
an elevated conversion of LC3-I to LC3-II (Fig. 4a) and higher
numbers of punctate LC3-positive structures (Fig. 4b), and more
EM structures compatible with AVs (Fig. 4c), whose nature was
conﬁrmed by correlated light electron microscopy (CLEM; Sup-
plementary Fig. 5a).
An increased number of AVs might arise from the stimulation
of autophagosome biogenesis or from alteration of their
degradation by lysosomes. To distinguish between these two
possibilities, we treated at two different time points (2h and 4 h)
control and MMA cells with Baﬁlomycin A1 (BfnA1), a
lysosome–proteolysis inhibitor that blocks the cellular degrada-
tion of autophagosomes that subsequently accumulate. Treatment
of MMA cells with BfnA1 further increased the already elevated
steady levels of LC3-II and the numbers of punctate LC3+
structures at two different time points where any changes would
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reﬂect altered autophagosome biogenesis (Fig. 4a, b; ref. 31).
These cellular alterations were not associated with changes in
autophagosome trafﬁcking (as measured by LC3/LAMP1-positive
structures in cells in response to short incubations with non-
saturating concentration of BfnA1; Supplementary Fig. 5b); nor
in autophagosome–lysosome fusion, as testiﬁed by augmented
protein levels of Rab7—a small GTPase protein that regulates
autophagosome–lysosome fusion31 (Supplementary Fig. 5c); nor
in lysosome dynamics, as scored by the abundance of lysosome-
associated protein LAMP1 and cathepsin-D (Supplementary
Fig. 5c); nor in lysosome-based degradative capacity, as
monitored by Bodipy-FL-Pepstatin A, a ﬂuorescence-tagged
probe that binds to the active site of cathepsin-D in acidic
lysosomes (Supplementary Fig. 5d), implying that the MMUT
deﬁciency stimulates autophagosome biogenesis rather than
slowing down their degradation.
The connection between MMUT deﬁciency and induction of
autophagy was substantiated by the increased formation of
SQSTM1/p62+ aggregates containing polyubiquitinated proteins
in MMA cells, despite unchanged levels of SQSTM1 and
unmodiﬁed activity of the proteasome (Supplementary Fig. 5e,
f). These changes were rescued by treating the MMA cells with
the mitochondrially targeted ROS scavenger mito-TEMPO (MT;
10 μM for 24 h; Supplementary Fig. 5f), in line with recent
observations that increased levels of SQSTM1/p62 might enable a
more efﬁcient autophagy to maintain cellular homeostasis during
oxidative stress32,33. Similar ﬁndings were observed in human
kidney: LC3-marked autophagy vesicles and SQSTM1+ aggre-
gates remarkably accumulated in kidney tubules from a patient
with MMA (Supplementary Fig. 5g).
Furthermore, the upstream signalling cascade regulating
autophagy, such as mTORC1 complex, was markedly reduced
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in MMA compared to control cells (Fig. 4d). This was paralleled
by activation of the ULK1 complex—the most upstream
autophagy machinery controlling autophagosome biogenesis, as
indicated by increased protein levels of ULK1 complex subunits
FIP200 and Atg13 (Fig. 4e) and numbers of initiation foci
containing ULK1 complex subunit Atg13 (Fig. 4f, top panel). In
turn, these changes were reﬂected by the heightened production
of the autophagy-relevant pool of Ptd-Ins3P (Fig. 4f, middle
panel), triggering the recruitment of downstream autophagy
effector WIPI2 that stimulates the biogenesis of autophagosomes
(Fig. 4f, bottom panel). Conversely, exposing MMA cells to the
class III phosphoinositide 3-kinase (PI3K) vacuolar protein
sorting 34 (Vps34) kinase inhibitor SAR405, which blocks the
production of Ptd-Ins3P34, prevented the LC3-I-to-LC3-II
conversion, hence the formation of autophagosomes induced by
the MMUT deﬁciency (Supplementary Fig. 6a, b). Collectively,
these data suggest that MMUT deﬁciency stimulates autophagy
by regulating, at least in part, upstream signalling cascades that
regulate autophagosome biogenesis.
MMUT deﬁciency impairs degradation of damaged mito-
chondria. Considering the persistence in MMA cells of dys-
functional (ROS overproducing) mitochondria and high numbers
of autophagic vesicles/autophagosomes, we reasoned that MMUT
deﬁciency might sabotage the mitophagy-mediated demolition of
MMA-damaged mitochondria. To verify our hypothesis, we
treated both control and MMA cells with Rotenone to damage
mitochondria and selectively activate their mitophagy-mediated
degradation. After 24 h treatment with Rotenone, control cells
showed a marked decrease in overall mitochondrial proteins
(Fig. 5a) and in the ratio between mt-DNA and n-DNA (Fig. 5b),
whereas both parameters were conversely retained in MMA
cells. These changes were veriﬁed by measuring the overall
mitochondrial proteins in cells cultured with other mitochondria-
damaging compounds such as the electron transport chain inhi-
bitors Oligomycin and Antimycin A (4 and 0.8 μM, respectively;
Supplementary Fig. 7a). The depletion of MMUT did not alter the
content of other cellular organelles producing ROS, such as
peroxisomes, both under normal and autophagy/mitophagy-
evoked conditions (Supplementary Fig. 7b), nor the dynamics and
homeostasis of endolysosome system (Supplementary Fig. 5c, d).
As the loss of MMUT function results in a block of basal and
stress-induced mitophagy, we hypothesized that MMUT deﬁ-
ciency might paralyse the delivery of MMA-damaged mitochon-
dria to autophagy–lysosome degradation systems. To tackle this
hypothesis, we utilized the ratiometric pH-sensitive imaging-
based method22,35 to measure the delivery of dysfunctional
mitochondria (which were labelled by the mitochondrially
targeted form of a ﬂuorescent Keima protein, mt-Keima) to
lysosomes. When damaged mitochondria are delivered and
engulfed within autolysosomes (e.g. mito-autolysosome), a
spectral shift of mt-Keima occurs owing to the low pH (Fig. 5c).
We validated mt-Keima as a bona ﬁde reporter of mito-
autolysosome formation in autophagy-deﬁcient PT cells derived
from the kidneys of Atg7ﬂ/ﬂ mice (adenovirus-mediated, Cre-
induced deletion of ﬂoxed Atg7 alleles; Supplementary Fig. 7c;
ref. 36), or from kidneys of Pink1 or Prkn2 (encoding Parkin)
knockout (KO) mice (Supplementary Fig. 7e, f), and treated with
Rotenone. Compared to controls cells, the deletion of Atg7, Pink1,
or Prkn2 was reﬂected by a loss of the expected shift of mt-Keima
from a green mitochondrial to a red punctate appearance
(Supplementary Fig. 7d, g) induced by Rotenone. Of note, basal
mitophagy was reduced in autophagy (Atg7)-deﬁcient PT cells
(Supplementary Fig. 7d) whereas it was comparable in wild type
and Pink1 or Prkn2 KO cells (Supplementary Fig. 7g), in line with
recent reports suggesting that basal mitophagy might occur
independently of Pink1 in mouse tissues of high metabolic
demand including the kidneys37.
Next, we similarly expressed mt-Keima in both control and
MMA cells (Supplementary Fig. 7h) and exposed the cells to
Rotenone to follow the delivery of damaged mitochondria to
lysosomes. After 24 h Rotenone treatment, control cells showed a
substantial green-to-red ﬂuorescent shift—indicative of delivery
of damaged mitochondria to lysosomes, whereas this shift was
abolished in MMA cells (Fig. 5c). Notably, under control
conditions, MMA cells displayed lower steady-state mt-Keima
red/green ratio values than controls, suggesting that MMUT
deﬁciency compromises the delivery of damaged mitochondria to
autolysosomes in both normal and stress-induced conditions
(Fig. 5c).
Mitophagy-mediated quality control in COX10 deﬁciency. In
order to test whether the altered mitophagy associated with the
functional loss of MMUT is present in other mitochondrial dis-
eases, we investigated the contribution of mitophagy-mediated
removal and quality control systems in a model of impaired
cytochrome oxidase assembly (COX10 deﬁciency)—taken as a
paradigm of primary mitochondrial disease38. We transduced
PT cells derived from the kidneys of ﬂoxed Cox10ﬂ/ﬂ mice with
Cre-recombinase bearing adenoviral particles to conditionally
inactivate the ﬂoxed Cox10 alleles in vitro (Supplementary Fig. 8a,
b). The deletion of Cox10 was veriﬁed by reverse transcription-
quantitative PCR (Supplementary Fig. 8c) and indirectly by
immunoblotting for mitochondrial COX IV (Supplementary
Fig. 8d; ref. 39). The Cox10-deleted cells showed signiﬁcant
mitochondrial alterations (e.g. decreased membrane mitochon-
drial potential and increased generation of mitochondrial ROS;
Supplementary Fig. 8e, f). These alterations were not associated
with major changes in mitochondrial content as indicated by
comparable ratios of mt-DNA/n-DNA (Supplementary Fig. 8g)
and by similar levels of mitochondrial proteins (Supplementary
Fig. 8h) between control and Cox10-deleted PT cells. Notably,
under normal conditions Cox10-deleted PT cells displayed higher
steady-state mt-Keima red/green ratio values than control cells
(Supplementary Fig. 8i), which were reﬂected by elevated tran-
script levels of mitophagy regulating gene Pink1 (Supplementary
Fig. 8j). Treatment with Rotenone induced in both control and
Cox10-depleted PT cells the green-to-red ﬂuorescent shift—
indicative of delivery and engulfment of damaged mitochondria
within autolysosomes (Supplementary Fig. 8i). Collectively, these
data suggest that mitochondrial alterations encountered in
Cox10-deﬁcient kidney cells are not linked to anomalies in
mitophagy-mediated degradation, in contrast to the defective
mitochondrial homeostasis and mitophagy-mediated quality
control caused by MMUT deﬁciency in patient-derived kidney
tubular cells.
MMUT deﬁciency skews PINK1/Parkin-mediated mitophagy.
The PINK1/Parkin-induced mitophagy maintains the quality of
the mitochondrial network by priming dysfunctional mitochon-
dria for autophagy‒lysosome degradation pathways40. Therefore,
we hypothesized that MMUT deﬁciency might compromise the
PINK1/Parkin-mediated priming of MMA stressed mitochondria
to autophagic–lysosomal degradation. Due to the lack of com-
mercially available antibodies able to detect endogenous PINK1,
we resorted to the translocation of Parkin to damaged mito-
chondria—a key downstream step following the activation of
PINK1—as a bona ﬁde reporter to assess the PINK1/Parkin-
priming mechanisms22,41,42. We labelled the mitochondrial net-
work by transducing both control and MMA cells with an
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adenovirus that expresses the mitochondrially targeted green
ﬂuorescent protein (Ad-mito-GFP). Twenty-four hours post-
transduction, we exposed the mt-GFP-expressing cells to Rote-
none (5 μM for 4 h) and scored the translocation of Parkin to
mito-GFP-ﬂagged mitochondria by confocal microscopy42. Using
a validated α-Parkin antibody (see Supplementary Fig. 10e), we
observed that Rotenone treatment expectedly heightened the
numbers of Parkin+ clusters and the translocation of Parkin to
mito-GFP+-damaged mitochondria in control cells (Fig. 5d‒f),
indicating a proper PINK1/Parkin-mediated quality control.
Conversely, MMA cells displayed a decrease in numbers of Parkin
+ clusters and translocation of Parkin to damaged mitochondria
at baseline and in Rotenone-evoked stress conditions (Fig. 5d‒f).
These changes were complemented by the lack of engulfment of
damaged mitochondria within EM-compatible autophagy
vacuoles in MMA cells (Fig. 5g), supporting the concept of
defective marking of diseased mitochondria for autophagy‒lyso-
some-based degradation.
The role of defective PINK1-mediated quality control and
surveillance systems was further assessed by transducing MMA
cells with an adenovirus that expresses human hemagglutinin
(HA)-tagged PINK1 (Ad-HA-PINK1). The functional re-
expression of PINK1 at mt-GFP-ﬂagged mitochondria in MMA
cells markedly increased the numbers of Parkin+ clusters and
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rescued the translocation of Parkin to MMA-damaged mitochon-
dria (Fig. 6a‒c), inducing their delivery and degradation by
autophagy‒lysosome systems, as indicated by mt-Keima reporter
(Fig. 6d; Supplementary Fig. 9a) and analyses of mitochondrial
proteins (Fig. 6e). In parallel, the functional re-expression of
PINK1 improved mitochondrial functions in MMA cells
(Fig. 6f–h; Supplementary Fig. 9b, c), compared to cells
transduced with empty vector.
Mmut deletion damages mitochondria causing stress. To cau-
sally demonstrate the link between the loss of the enzyme
MMUT, PINK1-directed mitophagy, mitochondrial dysfunctions
and epithelial stress, we used gain and loss-of-function inter-
ventions in kidney cells carrying ﬂoxed Mmut alleles (Mmutﬂ/ﬂ).
TheMmutﬂ/ﬂ mice do not show any clinical phenotype, they have
normal growth and display normal metabolite levels43. Primary
PT cells derived from Mmutﬂ/ﬂ mouse kidneys were transduced
HA/mito-GFP/DAPI Parkin/mito-GFP/DAPI
Co
nt
ro
l; 
+A
d-
m
ito
-G
FP
M
M
A;
 +
Ad
-m
ito
-G
FP
Ad
-N
ul
l
Ad
-N
ul
l
Ad
-H
A-
PI
N
K1
Ad
-H
A-
PI
N
K1
100
200
300
400
500
0
Pa
rk
in
+
 
st
ru
ct
ur
es
n
u
m
be
r p
er
 c
el
l
10
20
30
40
0
Ad-Null
Ad-HA-PINK1
0
2
6
4
8
m
ito
-G
FP
/P
ar
kin
+
 
st
ru
ct
ur
es
%
 o
f t
ot
al
 m
ito
-G
FP
m
t-K
ei
m
a 
re
d/
gr
ee
n
flu
or
es
ce
nc
e 
in
te
ns
ity
 ra
tio
NS
***
***
*** ***
**
*
NS
NS
a b c d
Co
ntr
ol
MM
A
Co
ntr
ol
MM
A
Co
ntr
ol
MM
A
e
Ad-Null
Ad-HA-PINK1
–+
– + – +
–+
Control MMA
HA
MT-CO2
VDAC1
Cyt C
Cyt C
Pr
ot
ei
n 
ta
rg
et
s/
G
AP
DH
GAPDH
0.5
1.0
2.0
1.5
0
Ad-Null
Ad-HA-PINK1
*
***
**
**
*
*NS
NS
Co
ntr
ol
MM
A
Co
ntr
ol
MM
A
Co
ntr
ol
MM
A
MT-CO2 VDAC1
50
25
15
37
37
MW
(kDa)
Ad-Null
Ad-HA-PINK1
Ad-Null
Ad-HA-PINK1
Ad-Null Ad-Null
Ad-HA-PINK1 Ad-HA-PINK1
Ad-Null
Ad-HA-PINK1
Ad-Null
Ad-HA-PINK1
0
0.5
1.0
1.5
0
0.5
1.0
1.5
2.0
0
500
1000
1500
2000 2000
1600
1200
1000
800
600
400
200TM
R
M
/M
ito
Tr
ac
ke
r
flu
or
es
ce
nc
e 
in
te
ns
ity
 ra
tio
M
ito
SO
X/
M
ito
Tr
ac
ke
r
flu
or
es
ce
nc
e 
in
te
ns
ity
 ra
tio
O
CR
 (p
mo
l/m
in/
10
4  
ce
lls
)
O
CR
 (p
mo
l/m
in/
10
4  
ce
lls
)
Control MMA
Basal 
respiration
Maximal
respiration
ATP
production
***
***
***
***
***
NS
#
*
*
*
*
*
*
**
NS
NS
Oligo FCCP Rot+Ant
f g h
6040200 80
Time (min)
Fig. 6 Rescue of mitochondrial function and homeostasis by re-expressing PINK1 in MMA kidney cells. a–c Cells were transduced with adenovirus
particles expressing mitochondrially targeted GFP (Ad-mito-GFP, green) and with adenovirus particles bearing either Null or HA-PINK1. Cells were
immunostained for HA (red) and Parkin (red). a Representative images and b quantiﬁcation of numbers of Parkin+ structures in a cell. Number of control
cells transduced with Null (n= 25) or HA-PINK1 (n= 39) and MMA cells transduced with Null (n= 57) or HA-PINK1 (n= 55). c Quantiﬁcation of mito-
GFP/Parkin+ structures (expressed as the percentage of total mitochondria); n ≥ 4 randomly selected and non-overlapping ﬁelds of views per each
condition. Nuclei counterstained with DAPI (blue). d, e Null and HA-PINK1-expressing cells were transduced with adenovirus particles bearing mt-Keima.
d Confocal microscopy-based quantiﬁcation of the red/green ﬂuorescence intensity ratio in a cell. Number of control cells transduced with Null (n= 46) or
HA-PINK1 (n= 38) and MMA cells transduced with Null (n= 51) or HA−PINK1 (n= 54). e Representative immunoblotting and quantiﬁcation of the
indicated mitochondrial proteins; n= 5 biologically independent experiments. f, g Cells were loaded with (f) TMRM (green) or (g) MitoSOX (green) and
MitoTracker (red), and analysed by confocal microscopy. Quantiﬁcation of TMRM/MitoTracker or MitoSOX/MitoTracker ﬂuorescence intensity ratio in a
cell. Number of control cells transduced with Null (n= 43) or HA-PINK1 (n= 62) and MMA cells transduced with Null (n= 83) or HA-PINK1 (n= 84) for
TMRM/MitoTracker. Number of control cells transduced with Null (n= 38) or HA-PINK1 (n= 56) and MMA cells transduced with Null (n= 59) or HA-
PINK1 (n= 64) for MitoSOX/MitoTracker. h Oxygen consumption rate (OCR) and individual parameters for basal respiration, ATP production and maximal
respiration. OCRs were measured at baseline and after the sequential addition of Oligomycin (Oligo, 1 μM), FCCP (0.5 μM) and Rotenone (Rot; 1 μM)+
Antimycin A (Ant; 1 μM). Values in a–h are pooled from three biologically independent experiments. Plots represent mean ± SEM. One-way ANOVA
followed by Bonferroni’s post hoc test, *P < 0.05 and ***P < 0.001 relative to control or MMA cells transduced with Null in b, d, f and g. Two-tailed
Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001 and #P < 0.0001 relative to control and MMA cells transduced with Null in c, e and h. Scale bars,10 μm.
NS non-signiﬁcant. Source data are provided as a Source Data ﬁle.
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with adenovirus particles bearing Cre-recombinase to con-
ditionally delete Mmut in vitro (Fig. 7a, b).
The deletion of Mmut was reﬂected by augmented levels of
MMA (Fig. 7c), and by reduced engulfment of damaged and/or
dysfunctional mitochondria (e.g. decreased membrane potential
and altered bioenergetics proﬁling; Fig. 7d, e) within autolyso-
somes (as scored by reduced mt-Keima red/green ﬂuorescence
ratio; Fig. 7f). Under these conditions,Mmut-deleted cells showed
no signiﬁcant increase in overall mitochondrial proteins com-
pared to control cells (Supplementary Fig. 9d). In line with
defective mitochondrial disposal, Mmut-deleted PT cells exhib-
ited elevated mitochondrial oxidative stress (Fig. 7g) and cell
damage (Lcn2 overproduction; Fig. 7h), which were abolished by
restoring PINK1-directed mitophagy with an adenovirus expres-
sing (HA)-tagged PINK1 (Fig. 7g, h; Supplementary Fig. 9e).
Conversely, CRISPR/Cas9-mediated KO of PINK1 or PRKN2
(encoding Parkin) in human HAP-1 cells (Supplementary Fig. 10)
led to mitochondrial alterations, i.e. decreased membrane potential
(Supplementary Fig. 11a), reduced bioenergetics proﬁling and
elevated mitochondrial ROS production (Supplementary Fig. 11b,
c), which were similar to, albeit milder than, those encountered in
patient-and-in Mmut-deleted cells. Notably, we did not detect
any differences in mitochondrial morphology between PINK1
and PRKN2 wild type and KO cells (Supplementary Fig. 11d).
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Representative images and quantiﬁcation of MitoSOX ﬂuorescence intensity, n≥ 4 randomly selected and non-overlapping ﬁelds of views per condition,
with each containing ~10 cells. h Representative immunoblotting and quantiﬁcation of Lcn2, n= 4 biologically independent experiments. β-actin was used
as a loading control. Values in d–g are pooled from three biologically independent experiments. Plots represent mean ± SEM. Asterisks denote non-speciﬁc
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as a Source Data ﬁle.
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Taken together, these data suggest that the deﬁciency of Mmut
impedes the PINK1-induced translocation of Parkin to MMA-
damaged mitochondria, halting their delivery and subsequent
degradation by autophagy‒lysosome systems. In turn, these cellular
defects promote the accumulation of dysfunctional (ROS over-
producing) mitochondria that ultimately trigger epithelial stress
and kideny damage.
Drug–disease network perturbations in MMA cells. We used a
drug–disease network-based computational modelling approach
(Mantra 2.0; Mode of Action by Network Analysis; http://mantra.
tigem.it; ref. 44) to identify potential druggable pathways to
overcome cellular dysfunctions associated with MMA. Man-
tra elucidates genome-wide targetable candidates by system-
atically matching disease gene signature (Supplementary
Fig. 12a), here derived from the comparison of expression proﬁles
between MMA and their related control cells (Supplementary
Fig. 12b, c; Supplementary Data 1), against a library of 1309 small
bioactive drug compounds. Predictions for drug–disease pairs
were based on the hypothesis that if a drug reverses the disease
gene signature, that drug might potentially target disease-relevant
biological pathways44. Based on this assumption, the top-35 drug
compounds transcriptionally closer to the inverse disease gene
proﬁle were identiﬁed. To determine the targeted-biological
pathways in MMA, we transcriptionally phenotyped the top-35
drug compounds by performing Drug Set Enrichment Analysis
(DSEA45)—a tool identifying, from transcriptional responses, the
molecular pathways that are signiﬁcantly modulated by drug
compounds in a set. We run DSEA using as pathway databases
Gene Ontology terms: biological process, molecular function and
cellular component. Interestingly, DSEA revealed that the top-
scored drug compounds modulate redox homeostasis-related
pathways (Fig. 8a), in line with the mitochondrial oxidative stress
encountered in MMA cells and with recent mouse transcriptomic
proﬁling denoting a chronic activation of stress-related pathways
in a transgenic mouse model expressing Mmut in the muscle26. It
also yielded candidates affecting pathways that regulate mito-
chondrial homeostasis and functioning such as calcium import,
fatty acid β-oxidation and cellular respiration; or pathways that
control mitochondrial dynamics such as fusion; or pathways that
modulate cellular responses to mitochondrial stress (Fig. 8a).
These in silico analyses strongly support that mitochondria-
targeting strategies might potentially reverse disease phenotype in
MMA cells.
Mitochondrial targeting in MMA cells and animal models.
Inspired by the biological evidence and the MANTRA analysis,
we tested whether mitochondria-targeted interventions might
correct phenotypes in MMA. Control and MMA cells were cul-
tured in the presence and in the absence of a mitochondria-
targeted antioxidant mito-TEMPO (MT, 10 μM for 24 h), which
rescues mitochondrial-based cell dysfunctions associated with the
lysosome storage disease cystinosis46. Despite unchanged levels of
MMA metabolite (Fig. 8b), treatment with MT effectively
recovered mitochondrial morphology (as scored by the presence
of curvilinear or elongated mitochondria; Fig. 8c) and partially
the homeostasis of mitochondrial network (as testiﬁed by
immunoblotting analyses for mitochondrial proteins; Fig. 8d),
improved mitochondrial functionality and bioenergetics (Fig. 8e),
lowered the formation of SQSTM1+ aggregates containing
polyubiquitinated proteins (Supplementary Fig. 5f), and neu-
tralized mitochondrial oxidative stress (Fig. 8f) and LCN2 over-
production (Fig. 8g) in MMA cells.
To explore the translational potential of these ﬁndings, we
treated mmut-deﬁcient zebraﬁsh larvae with low, non-toxic doses
of the mitochondrially targeted antioxidant MitoQ (200 nM for
24 h). Treatment with MitoQ effectively reduced mitochondrial
oxidative stress (Fig. 9a), improved the behavioural phenotype
(Fig. 9b) and reduced the excessive mortality observed in
mmut–deﬁcient zebraﬁsh larvae (Fig. 9c), in the absence of any
signiﬁcant changes in the MMA levels (Fig. 9d). Taken together,
these ﬁndings suggest that repairing mitochondrial function
might serve as an attractive therapeutic strategy for treating
MMA.
Discussion
The proper functioning of mitochondria is crucial for the
homeostasis of specialized cell types, for instance those requiring
high ATP levels for reabsorptive/transport activities23,47–49.
Inherited defects in mitochondrial-localized proteins and/or
enzymes, as exempliﬁed by MMA, drive the accumulation of
potentially toxic metabolites within mitochondrial matrix, pro-
moting ultrastructural and/or functional alterations that ulti-
mately cause life-threatening metabolic complications and organ
dysfunction10–13. Here, combining gain- and-loss-of function
interventions, both in vitro and in vivo, we decipher the link
between mitochondrial abnormalities induced by MMUT deﬁ-
ciency and anomalies in PINK1/Parkin-mediated quality control
and surveillance systems, triggering a level of mitochondrial
dysfunction that drives epithelial stress and kidney damage
in MMA.
Kidney tubular cells derived from MMA patients and zeb-
raﬁsh lacking the enzyme MMUT exhibit mitochondrial frag-
mentation and lower membrane potential, impaired respiration
and ATP production, and heightened mitochondrial ROS,
generating epithelial stress and cell damage (Fig. 10). In parti-
cular, MMUT deﬁciency disables the PINK/Parkin-mediated
mitophagy, leading to the accumulation of MMA-damaged
and/or dysfunctional mitochondria that trigger cellular stress.
Unbiased drug–disease network perturbation modelling pre-
dicted targetable biological processes including redox home-
ostasis whose modulation repairs mitochondria in patient-
derived cells and alleviates disease-relevant phenotypes in a
zebraﬁsh model of MMA. These ﬁndings reveal the importance
of mitophagy-mediated organelle quality control systems in
safeguarding the functioning and homeostasis of the mito-
chondrial network, and offer potential therapeutic strategies for
repairing mitochondrial dysfunctions in MMA and in other
mitochondrial-related human diseases.
The epithelial cells that form the kidney tubules are enriched in
mitochondria to sustain their specialized transport functions and
integrity23. Defects that impair mitochondrial protein home-
ostasis or assembly might drastically lead to kidney tubule dys-
function in various types of diseases50. MMA patient-derived
kidney cells show fragmented mitochondria and a marked
increase in the abundance of mitochondrial DNA and resident
mitochondrial proteins, suggesting that MMUT deﬁciency alters
the homeostasis of the mitochondrial network. Furthermore,
MMA cells display decreased mitochondrial membrane potential
and reduced mitochondrial bioenergetics. These dysfunctions
result in the generation of a large amount of oxygen radicals and
cellular stress, which are observed in other mitochondrial dis-
eases51. A similar accumulation of morphologically aberrant and
dysfunctional mitochondria is observed in the kidney tubule cells
of MmutKO/KI mice, demonstrating the key role of MMUT
function for the mitochondrial network homeostasis and func-
tion. However, despite the metabolic and mitochondrial
abnormalities, the MmutKO/KI mice develop no structural chan-
ges nor signiﬁcant kidney failure, thus failing to recapitulate the
kidney disease associated with MMA.
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To overcome this difﬁculty, we established the ﬁrst mmut-
knockout zebraﬁsh model using CRISPR/Cas9 genome editing.
The patterning of the kidney tubule is remarkably conserved in
the zebraﬁsh pronephros versus mammalian kidney, including
junctional complexes, endolysosomal apparatus and receptors
and transporters52. Deﬁciencies in genes encoding receptors,
enzymes and transporter that cause tubular dysfunction in
humans have been shown to trigger similar pathological changes
in zebraﬁsh46,53–55. Further characteristics including high
fecundity, unrivalled optical transparency and the possibility of
housing in multi-well plates offer unique opportunities to
perform (high-throughput) phenotypic screens in an in vivo
context56.
Analogous to the metabolic and mitochondrial alterations
encountered in MmutKO/KI and patient-derived kidney cells, the
mmut–deﬁcient zebraﬁsh exhibit altered mitochondrial mor-
phology and excessive mitochondrial damage, with an exag-
gerated mitochondrial oxidative stress and markedly decreased
mitochondrial bioenergetics ﬂux rates when compared to
their control littermates. The demonstration of this conserved
connection will require a more comprehensive elucidation of
similarities and differences between zebraﬁsh and human
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particles bearing the mitochondrially targeted GFP (Ad-mito-GFP, green). After 24 h post-transduction, the cells were treated with MT and analysed by
confocal microscopy. Representative inverted images and quantiﬁcation of mitochondrial circularity or interconnectivity. Circularity: n= 15 cells per each
condition. Interconnectivity: n= 15 untreated and MT-treated control cells, n= 15 and n= 13 untreated and MT-treated MMA cells, respectively. One-way
ANOVA followed by Bonferroni’s post hoc test, *P < 0.05 and ***P < 0.001 relative to untreated control or MMA cells. d Representative immunoblotting
and quantiﬁcation of the indicated mitochondrial proteins. GAPDH was used as a loading control. e Oxygen consumption rate (OCR) and individual
parameters for basal respiration, ATP production and maximal respiration. OCRs were measured at baseline and after the sequential addition of Oligomycin
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cell). Number of untreated (n= 36) or MT-treated (n= 28) control cells and number of untreated (n= 51) or MT-treated (n= 28) MMA cells. One-way
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quantiﬁcation of LCN2, n= 4 biologically independent experiments. β-actin was used as a loading control. Plots represent mean ± SEM. Values in b–f are
pooled from three biologically independent experiments. Two-tailed Student’s t-test, *P < 0.05, **P < 0.01, ***P < 0.001 and #P < 0.0001 relative to
untreated control or MMA cells in d, e and g. Scale bars, 10 μm. NS non-signiﬁcant. Source data are provided as a Source Data ﬁle.
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14729-8
12 NATURE COMMUNICATIONS |          (2020) 11:970 | https://doi.org/10.1038/s41467-020-14729-8 | www.nature.com/naturecommunications
mitochondrial biology. The mmut-deﬁcient zebraﬁsh showed an
MMA disease-relevant phenotype, including liver/kidney mito-
chondriopathy, impairment of the behavioural phenotypes and
an excess of mortality. Of note, these two features are rescued by
feeding mutant zebraﬁsh with a low-protein diet—a strategy used
in MMA patients as it prevents the accumulation of methylma-
lonic acid14. Intriguingly, our ﬁndings revealed that restoring
mmut activity in the liver, which normalizes the levels of
methylmalonic acid metabolite and blunts the excessive mortality,
does not protect the mmut-deﬁcient zebraﬁsh from the abnormal
swimming phenotype. The latter observation suggests that mmut-
induced mitotoxicity in other cell types and organs (e.g. central
nervous system, optic nerve and/or muscle) might govern the
phenotypes encountered in mmut-deﬁcient zebraﬁsh.
The concept that mitochondrial dysfunctions and uncontrolled
cellular stress might contribute to the MMA disease is in line with
the observed correlation between mitochondrial dysfunction,
oxidative stress and circulating LCN2 in a cohort of patients with
MMA10,26. LCN2 is a secreted iron-transporting protein produced
by kidney tubules following cellular damage; it is associated with
kidney disease progression27 and metabolic disease57. Our studies
performed on aged MmutKO/KI mice did not show any signiﬁcant
increase in the levels of Lcn2, in plasma, urine and kidney. The
difference could reﬂect speciﬁc compensatory mechanisms10,26, or
a speciﬁc time-course of induction in MmutKO/KI mice29.
A central question is how the loss of the enzyme MMUT
disrupts mitochondrial network homeostasis and its function.
The ﬁrst line of defense to cope with mitochondrial damage is
represented by the cellular quality control system58. The latter
involves the degradation of dysfunctional mitochondria through
an evolutionary conserved, catabolic self-eating process called
macroautophagy (hereafter autophagy; ref. 58) and the renewal of
components through biogenesis20. Normally, these homoeostatic
processes sufﬁce to clean the cells of damaged organelles.
We ﬁrst noted that MMUT deﬁciency promotes autophagy.
Indeed, MMUT-deﬁcient cells show a heightened conversion of
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signiﬁcant. Source data are provided as a Source Data ﬁle.
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LC3-I to LC3-II, with increased autophagosome-associated LC3+
puncta as well as CLEM and/or EM structures compatible with
AVs. MMUT deﬁciency may affect autophagy either by stimu-
lating autophagosome biogenesis or by inhibiting the fusion
between autophagosomes and lysosomes or by controlling the
degradative function of lysosomes. These last hypotheses do not
sound plausible in view of the similar coalescence of LAMP1-
positive and LC3-positive vesicles and the unchanged lysosomal
dynamics and lysosomal-based cellular degradation under
MMUT-depleting conditions. Also, treatment with BfnA1 further
increased the already elevated steady levels of LC3-II and the
numbers of punctate LC3+ structures at two different time points
where any changes would reﬂect altered autophagy biogenesis.
Furthermore, downstream events regulating the degradation of
autophagosomes remained unchanged. Several mechanisms may
account for the stimulation of autophagy in MMUT-deﬁcient
cells: (1) reduced mTORC1 signalling, whose activity down-
regulates autophagy; (2) increased levels of ULK1 complex
subunits FIP200 and Atg13 and numbers of initiation foci con-
taining ULK1 complex subunit Atg13, whose activation regulates
autophagy machinery involved in autophagosome formation; (3)
augmented abundance of autophagy-relevant pool of Ptd-Ins3P,
which recruits downstream autophagy effector WIPI2, hence
stimulating autophagosome biogenesis; and (4) redox-dependent
formation of intracellular SQSTM1/p62+ aggregates containing
polyubiquitinated proteins, whose accumulation might activate
autophagy32. Thus, deﬁciency of MMUT may stimulates autop-
hagy by regulating upstream signalling cascades that regulate
autophagosome biogenesis, in line with recent studies stating
elevated autophagy markers in mitochondria-related diseases59
and dysregulation of autophagy–lysosome degradation pathways
in tissue samples from patients with MMA26.
A growing body of evidence suggests that exhausted mitochon-
dria are selectively targeted for autophagy by the PINK1/Parkin-
dependent pathways22. PINK1 and Parkin also regulate mito-
chondrial quality control through other pathways including
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Fig. 10 Proposed model depicting the link between mitochondrial dysfunctions and epithelial stress in MMA. In wild-type kidney cells (left),
mitochondrial stress (e.g. treatment with Rotenone) stimulates PINK1-induced translocation of Parkin to damaged mitochondria. This triggers mitophagy
and the subsequent disposal of dysfunctional mitochondria through autophagy–lysosome degradation systems, thereby safeguarding the homeostasis and
function of the mitochondrial network. By contrast, in MMA-affected kidney cells (right), the impaired PINK/Parkin-mediated mitophagy impedes the
delivery of damaged mitochondria and their degradation by autophagy‒lysosome pathways. This leads to accumulation of MMA-diseased mitochondria
and exacerbates the mitochondrial alterations induced by MMUT deﬁciency, including accumulation of toxic metabolites, collapsed mitochondrial
membrane potential (Δψm), and abnormal energetic proﬁling and increased mitochondrial ROS. These mitochondrial alterations generate epithelial stress,
causing ultimately cell damage (e.g. LCN2 overproduction). Drug–disease network perturbation modelling, based on transcriptome-wide proﬁles from
MMA patient-derived kidney cells against a large compendium of gene signatures derived from 1309 small bioactive drug compounds, identiﬁes targetable
disease-relevant cell biological pathways. The modulation of the identiﬁed targets (e.g. treatment with mitochondria-targeted ROS scavengers MT or
MitoQ) repairs mitochondrial dysfunctions, neutralizes epithelial stress and cell damage in MMA cells, and improves disease-relevant phenotypes in
mmut–deﬁcient zebraﬁsh.
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fusion/ﬁssion and biogenesis60. Mitochondrial damage activates the
mitochondria-associated kinase PINK1, which recruits and activates
Parkin’s E3 ubiquitin ligase activity, forming the basis of multiple
signalling events that culminate in the engulfment of damaged
mitochondria within lysosomes40,41. Considering the accumulation
of MMA damaged and dysfunctional mitochondria and the sti-
mulation of autophagy, we hypothesized that MMUT deﬁciency
might compromise the PINK1/Parkin-mediated priming of MMA
stressed mitochondria to autophagy–lysosome degradation systems.
Indeed, our studies show that MMA cells (1) fail to clear dys-
functional mitochondria in both normal and mitophagy (e.g.
treatment with Rotenone) induced conditions, as reﬂected by ana-
lyses of mitochondrial proteins and mitochondrial DNA; (2) fail to
deliver damaged mitochondria to autophagy–lysosome degradation
systems, as scored by the sensitive mt-Keima imaging-based
assay; and (3) show decreased recruitment of Parkin to MMA
mitochondria—a key downstream step following the activation of
PINK122,40,41. The dysfunction of the PINK1/Parkin-priming sys-
tem impacts on the delivery and elimination of ROS-producing
mitochondria through autophagy–lysosome degradation pathways,
triggering epithelial stress in MMA. Accordingly, restoring
mitophagy-mediated degradation through gain-of-function
approaches targeting PINK1-mediated priming was sufﬁcient to
rescue the mitochondrial network, preserving homeostasis in MMA
patient-derived kidney cells. Conversely, depleting MMUT in
PT cells reduces the PINK1-mediated delivery and engulfment of
mt-Keima tagged mitochondria within autophagy–lysosome
degradation compartments, promoting mitochondrial stress and
cell damage. Of note, when compared to control cells, Mmut-
deleted PT cells showed no increase in mitochondrial proteins,
contrasting with the situation observed in MMA patient-derived
kidney cells. The difference could reﬂect effects of chronic mito-
toxicity on mitochondrial clearance and quality control systems.
The genetic deletion of PRKN2 (encoding Parkin) or PINK1 in
HAP-1 cells leads to mitochondrial alterations similar to, albeit
milder than, those encountered in MMA patient derived- and in
Mmut-deleted kidney cells. Thus, anomalies in PINK1/Parkin-
mediated quality control might intersect the mitochondrial
alterations induced by MMUT deﬁciency and contribute to the
pathogenesis of MMA. The latter hypothesis is substantiated by
our comparative studies of Cox10 deletion—a model that reca-
pitulates a primary mitochondrial respiratory chain disease38.
The deletion of Cox10 in PT cells triggered mitochondrial
alterations that are not linked to anomalies in mitophagy-
mediated clearance and quality control systems, in contrast with
the dysregulation induced by Mmut deletion. The possibility of a
cumulative effect of the metabolic and/or mitochondrial pertur-
bations resulting from the MMUT deﬁciency and the loss of
PINK1/Parkin-mediated quality control systems is also supported
by the observation that patients harbouring loss-of-function
mutations of PINK1 causing Parkinson’s disease survive in the
absence of functional PINK1-dependent mitophagy pathway3. In
these patients, locomotor symptoms do not usually manifest until
the second and third decades of life, when a sufﬁcient level of
mitochondrial dysfunction is coupled to the loss of PINK1 to
have a detrimental effect on neuron integrity61.
The mechanisms by which MMUT deﬁciency suppresses
PINK1 signalling and mitophagy remain elusive. We speculate
that MMUT deﬁciency might alter the stability of PINK1 by
disabling the interaction with yet-to-be deﬁned factors that pro-
tect PINK1 from processing and degradation62. Alternatively,
MMUT deﬁciency might trigger stress-related post-translational
modiﬁcation such as S-nitrosylation that inhibits PINK1 kinase
activity, hence mitophagy63. Regardless of the mechanism(s)
involved, these ﬁndings support a role of the enzyme MMUT—
beyond its function in metabolism—in maintaining the
mitochondrial quality control system, hence epithelial integrity
and homeostasis.
There is an urgent need to identify targetable interventions in
the early course of MMA. Previous studies showed that kidney
dysfunction and levels of circulating Lcn2 could be abrogated in a
transgenic mouse model of MMA by administrating ubiquinone,
a bioavailable form of CoQ10 that acts on mitochondria, and
Vitamin E10. Using an in silico approach based on matching gene
expression proﬁle from patient-derived kidney cells against a
large compendium of small bioactive drug compounds, we
inferred that targeting mitochondrial oxidative stress might
reverse disease phenotypes associated with MMUT deﬁciency. In
particular, we explored the potential beneﬁt of mitochondria-
targeted antioxidants, which are clinically tested in a variety of
diseases64. Treatment of MMA kidney cells with mito-TEMPO
restored partially mitochondrial homeostasis, improved mito-
chondrial function, normalized mitochondrial ROS and autop-
hagy markers, and prevented the overproduction of LCN2.
Furthermore, treatment with low, non-toxic doses of MitoQ
alleviated the mitochondrial oxidative stress and ameliorated
behavioural phenotypes and blunted the excessive mortality in
the mmut-deﬁcient zebraﬁsh model of MMA. Importantly, both
pharmacological interventions did not modify the levels of MMA
metabolite in either MMA cells or mmut-deﬁcient zebraﬁsh,
supporting the concept that mitochondrial targeting acts inde-
pendently of the elevation of toxic MMA metabolites.
In conclusion, we identify a pathway that links a genetic
deﬁciency of a mitochondrial enzyme with mitophagy dysfunc-
tion and accumulation of damaged mitochondria that generate
epithelial stress and tissue damage. These ﬁndings substantiate
the role of PINK1/Parkin-directed mitophagy in safeguarding
mitochondrial network homeostasis, which is crucial for the
properly functioning of specialized epithelial cells. Antioxidant
compounds speciﬁcally targeting mitochondria offer a promising
therapeutic strategy for repairing mitochondria in MMA and
other mitochondrial disorders.
Methods
Antibodies, reagents and cell lines. Anti-MMUT (Abcam, ab67869, 1:200), anti-
SDH (Abcam, ab14715, 1:500), anti-PDHA1 (Abcam, ab110334, 1:500), anti-MT-
CO2 (Abcam, ab110258, 1:500), anti-VDAC1 (Cell Signaling Technology, 4866,
1:500), anti-COX IV (Abcam, ab14744, 1:500), anti-cytochrome C (Abcam,
ab110325, 1:500), anti-SOD1 (Santa Cruz Biotechnology, SC-11407, 1:500), anti-
LCN2 (Abcam, ab63929, 1:500), anti-ATP5B (Abcam, ab14730, 1:500), anti-LC3
(MBL, PM036, 1:200), anti-phospho ULK1 (Ser757; Cell Signaling Technology,
6888, 1:200), anti-phospho-S6 Ribosomal Protein (Ser235/236) (Cell Signaling
Technology, 4858, 1:500), anti-S6 Ribosomal Protein (Cell Signaling Technology,
2217, 1:500), anti-phospho-4E-BP1 (Ser65; Cell Signaling Technology, 9451,
1:500), anti-4E-BP1 (Cell Signaling Technology, 9644, 1:500), anti-ULK1 (Cell
Signaling Technology, 8054, 1:200), anti-FIP200 (Cell Signaling Technology, 12436,
1:500), anti-ATG13 (Cell Signaling Technology, 13468, 1:200), anti-WIPI2
(Abcam, ab105459, 1:200), mCherry-2XFYVE Ptdins-3P-binding domain (1:100)
were kindly provided by Dr. J. Gallop (University of Cambridge), anti-Parkin
(Abcam, ab77924, 1:500 for IF and immunoblotting analyses), anti-Parkin (Santa
Cruz Biotechnology, SC-32282, 1:500; for immunoblotting analyses), anti-HA
(Roche, 11867423001, 1:500), anti-α-tubulin (Sigma Aldrich, T5168, 1:10,000),
anti-RFP (600-401-379, ROCKLAND), anti-UMOD (Meridian, K90071C, 1:500),
anti-AQP2 (Santa Cruz Biotechnology, sc-9882, 1:500), anti-CD3 (Abcam,
ab16669, 1:200), anti-Ly6G (Biosciences, 551459, 1:100), anti-LAMP1 (Santa Cruz
Biotechnology, sc-19992, 1/1000), anti-PMP70 (Sigma, SAB4200181, 1:500), anti-
ubiquitin (Santa Cruz Biotechnology, sc-8017, 1:1000), anti-SQSTM1/p62 (MBL,
PM045, 1:200), anti-cathepsin-D (Santa Cruz Biotechnology, sc-6486, 1:500), anti-
Rab7 (Abcam, 126712, 1/400), anti-β-actin (Sigma, A5441, 1/10,000), anti-ATG7
(Sigma, A2856,1/500), anti-GAPDH (Cell Signaling Technology, 2118, 1:1000),
Picro Sirius Red staining kit (Abcam, ab150681) were used. Compounds included
BfnA1 (Enzo Life Sciences, ALX-380-030, 250 μM), Rotenone (Sigma, R8875,
5 μM), mito-TEMPO (Enzo Life Sciences, ALX-430-150-M005, 10 μM), MG132
(Abcam, ab141003, 50 μM), MitoQ (Focus Biomolecules, 10-1363, 200 nM),
SAR405 (APExBIO, A8883; 5 μM), Oligomycin A (Sigma Aldrich, 495455, 4 μM),
and Antimycin A (Sigma Aldrich, A8674, 0.8 μM). The HeLa cell line was kindly
provided by Dr. L. Borsig (University of Zurich) and the Hap-1 cell line was
purchased from Horizon Discovery (www.horizondiscovery.com). The cells lines
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used here do not appear in the database of commonly misidentiﬁed cell lines
(International Cell Line Authentication Committee), except the HeLa cell line that
was analysed for the detection of Parkin expression in Supplementary Fig. 7f. All of
the cells used in this study were negatively tested for mycoplasma contamination
using MycoAlert™ Mycoplasma Detection Kit (LT07-118, Lonza, Switzerland).
Human kidney biopsies. Human kidney biopsies were obtained from an indivi-
dual patient with clinical diagnosis of MMA and from a healthy control (non-
transplanted, normal human kidney). Informed consent was obtained, and the use
of the human biopsy samples was in accordance with the ethical regulations at
Bambino Gesù Children’s Hospital and approved by the EURenOmics consortium
(FP7, 2007–2013, grant agreement no. 305608) and by the institutional review
board at Bambino Gesù Children’s Hospital.
Immunoﬂuorescence on human kidney samples. Parafﬁn blocks of human
kidney samples were sectioned into consecutive slices with a thickness of 6 μm
using a Leica RM2255 rotary microtome (Thermo-Fisher Scientiﬁc) on Superfrost
Plus glass slides (12-550-15, Thermo-Fisher Scientiﬁc). Before staining, slides were
deparafﬁnized in changes of CitriSolv (22-143-975, Thermo-Fisher Scientiﬁc) and
70% isopropanol. Antigen retrieval was accomplished by incubating in sodium
citrate buffer (1.8% 0.1 M citric acid, 8.2% 0.1 M sodium citrate, in distilled water,
pH 6.0) in a rice cooker for 30 min. The slides were blocked with phosphate-
buffered saline (PBS) blocking buffer (1% BSA, 0.2% non-fat dry milk in PBS) for
30 min and stained with primary antibody speciﬁc for LC3 and SQSTM1/p62 in
blocking buffer overnight at 4 °C. After two washes in 0.1% Tween 20 (v/v in PBS),
the slides were incubated with the corresponding ﬂuorophore-conjugated sec-
ondary antibodies (Life Technologies) diluted in blocking buffer at room tem-
perature for 1 h and counterstained with 1 μg Biotinylated Lotus Tetragonolobus
Lectin (LTL; B-1325 Vector Laboratories) and 1 µM 4′,6-diamino-2-phenylindole
dihydrochloride (DAPI; #D1306, Thermo Fischer Scientiﬁc). The slides were
subsequently mounted in Prolong Gold Anti-fade reagent (Life Technologies) and
images were acquired using the Leica SP8 confocal laser scanning microscope
(Center for Microscopy and Image Analysis, University of Zurich) as
described below.
Electron microscopy on human kidney samples. Biopsy specimens were
immersed in ice-cold 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4)
immediately after their extraction and sectioning, and ﬁxed for 4 h at 4 °C, carefully
handling samples to avoid ex vivo artefacts. After washing in cacodylate buffer,
kidney fragments were then post-ﬁxed in 1% osmium tetroxide for 1 h, dehydrated
through ascending grades of alcohol, and embedded in Epon resin (Electron
Microscopy Science, Hatﬁeld, PA). Ultrathin sections (70–75 nm) were cut on an
ultramicrotome (Leica reichert ultracut S), stained with uranyl acetate and lead
citrate, and examined with TEM (Jeol 1400 PLUS).
Measurement of the MMUT enzyme activity. Crude cell homogenates were
sonicated and 1 mM DL-2-[methyl-14C] methylmalonyl-CoA (ARC; speciﬁc activity
7.03MBq/mmol in assay) was added in the presence (total MMUT activity) and in
the absence (holo-MMUT activity) of the cofactor Adenosylcobalamin (AdoCbl;
50 µM) in darkroom safelight red conditions. The reaction was terminated by the
addition of 5 N KOH (Merck, Darmstadt, Germany). The samples were enriched
with succinic acid (Merck, Darmstadt, Germany) to visualize the succinate peak
during HPLC separation. Succinate and methyl malonate peaks were detected at
210 nm by an UV detector. Quantiﬁcation of the [14C] succinate fraction was
performed with Optiphase HiSafe2 counting cocktail (PerkinElmer) in a Tri-Carc
C1 900TR scintillator spectrometer (Packard). The protein concentration of the cell
lysates was determined using the Lowry method. The activity of the enzyme
MMUT is expressed as pmol succinate which is formed per minute per mg protein
[pmol/min/mg].
Measurement of the methylmalonic acid. Mouse tissues or cells were sonicated
and lysed in 100 µL of acetonitrile/10 mM ammonium formate 1:1 (v/v). The
concentration of methylmalonic acid was measured in an accredited laboratory
using the standard protocol from Recipe (Recipe, Munich, Germany) with some
minor adaptations. Brieﬂy, 50 µL of lysate or urine were mixed with 200 µL pre-
cipitation reagent containing the internal standard d3-methylmalonic acid (Recipe,
Munich, Germany). After vortexing the sample for 30 s, the protein precipitate was
removed by centrifugation for 5 min at 16,000 g and the clean supernatant is
transferred to a LC-MS vial, which is kept at 10 °C in a thermostatic autosampler
until LC-MS analysis. From each vial, 2 µL of sample were loaded and separated on
an ClinMass column (2.1 × 100 mm, Recipe, Munich, Germany), kept at 25 °C
using an Ultimate 3000XRS (Thermo Scientiﬁc, Olten, Switzerland) instrument
interfaced to a SCIEX TripleQuad 5500 (AB Sciex, Zug, Switzerland) mass spec-
trometer. The chromatography was performed at a ﬂow rate ~700 µL/min by using
mobile phase A (MPA) and B (MPB) from Recipe (Recipe, Munich, Germany).
The elution was achieved using a step gradient (100% MPA for 0.3 min, 70% MPA
for 0.3 min, 40% MPA for 0.7 min and 0% MPA for 0.1 min followed by 1.2 min at
100% MPA). The source parameters were the following: CAD= 7 psi, CUR=
30 psi, GS1= 60 psi, GS2= 70 psi, IS= 4.0 kV, TEM= 550 °C. Multiple reaction
monitoring (MRM) in negative ion mode is used to identify and quantify
methylmalonic acid (quan: 117/73; qual: 117/55) and d3-methylmalonic acid (quan:
120/76; qual: 120/58). A collision energy of −12V is used for the 117/73 and 120/76
transitions, while a collision energy of −31V is used for the 117/55 and 120/58
transitions. The declustering potential was −40 V for all four transitions.
Kidney tubular cells from urines of patients with MMA. Tubular epithelial cells
were derived from urines of either three healthy donors or three muto MMA
patients (Supplementary Table 1, ref. 25 and cultured in a selective medium con-
taining Dulbecco’s modiﬁed Eagle's medium and Ham’s F12 medium, supple-
mented with dialyzed fetal calf serum (FCS), insulin, hydrocortisone, selenite,
transferrin, hEGF, NAD, and 3,3,5 triiodo-L-thyronine. The identity of MMUT
mutations were conﬁrmed by Sanger sequencing. Conﬂuent cells were sub-
cultivated until third passage and, subsequently, immortalized using pRSVneo
vector containing SV40 DNA (pRNS1). Afterwards, immortalized kidney tubule
epithelial cells were characterized for morphology and expression of kidney mar-
kers, and MMUT protein and its enzymatic activity as described previously25.
Where indicated, lysosomal proteolysis was inhibited by adding BfnA1 (250 nM for
2 h and 4 h, unless otherwise stated). Where indicated, the mitochondrial damage
and the activation of mitophagy were triggered by treating the cells with Rotenone
(5 μM for 24 h) or with Oligomycin A and Antimycin (O/A; 4 and 0.8 μM,
respectively), in fresh culture medium for the indicated times. Where indicated, the
cells were starved by washing them with Hank’s balanced salt solution (55021C,
Sigma Aldrich) and placing them in nutrient-deprived medium. Where indicated,
the autophagy was inhibited by culturing the cells in presence or in absence of a
highly selective PIK3C3/Vps34 inhibitor SAR405 (5 μM in fresh culture medium
for 4 h). Where indicated, the cells were treated with the proteasome inhibitor
MG132 (5 μM in fresh culture medium). Where indicated, the cells were treated
with the mitochondrially targeted ROS scavenger Mito-TEMPO (MT; 10 μM in
fresh culture medium for 24 h; Enzo Life Sciences). The cells were processed and
analysed as described below.
Generation of PINK1 and PRKN2 knockout cell lines. PRKN2
(HZGHC003208c002) and PINK1 (HZGHC000798c008) KO cells were created
through CRISPR-Cas9 gene editing technology and purchased from Horizon
Discovery (www.horizondiscovery.com). The cells were tested negative for myco-
plasma contamination and subjected to PCR analysis, followed by Sanger
sequencing to identify CRISPR-Cas9-induced deletion. The cells were maintained
in Iscove’s modiﬁed Dulbecco’s medium (IMDM) supplemented with 10% dialyzed
FCS, 100 U/mL Penicillin, and 100 μg/mL Streptomycin. The cells were afterwards
processed and analysed as described below.
Generation and maintenance of mmut zebraﬁsh. pT7-gRNA and pT3TS-nCas9n
plasmids were obtained from Addgene (# 46759 and # 46757, respectively).
CRISPR-Cas9-targeted site (5′-GGGCCAGCAGGGTCTGTCTGTGG-3′) contains
a restriction site for AlwNI (CAGNNNCTG), which has been used for monitoring
CRISPR-Cas9-mediated mutation and genotyping. Oligonucleotides containing
sgRNA-targeting sequence were annealed and cloned into the Esp3I (BsmBI)-
digested pT7-gRNA vector (pT7-gRNA-mmut). The sequence of oligonucleotides
is CRISPR-mmut-S: 5′-TAGGGCCAGCAGGGTCTGTCTG-3′ and CRISPR-
mmut-AS: 5′-AAACCAG ACAGACCCTGCTGGC-3′. XbaI-linearized pT3TS-
nCas9n vector was used to produce Cas9 mRNA using mMESSAGE mMACHINE
T3 kit (Invitrogen). Both sgRNA-mmut and Cas9 messenger RNAs were co-
injected into two or four-cell stage TU zebraﬁsh (Danio rerio) embryos. For
detection of CRISPR-Cas9-induced deletion, genomic DNA was extracted from
2dpf embryos which developed normally. The CRISPR-Cas9-injected mosaic TU
embryos were raised to adulthood (F0) and outcrossed with wild-type TL zebraﬁsh.
The embryos were then raised to adulthood (F1) for screening of heterozygous
carriers. We identiﬁed a heterozygous carrier harbouring mmut+/del11 mutation
and (F1) generations were crossed again with wild-type TL zebraﬁsh to generate
(F2) heterozygous zebraﬁsh. Homozygous zebraﬁsh larvae carrying mmutdel11/del11
mutation were obtained from in-cross of (F2) heterozygous zebraﬁsh. Zebraﬁsh
were kept at day/night cycle of 14/10 h at 28 °C. Zebraﬁsh larvae were anaesthetised
by immersion in E3 medium (for 5 dpf) or system water (for 10 dpf) containing
168 µg mL−1 tricaine methane sulfonate (MS222, Sigma Aldrich) and analysed as
described below. Animal care and experimental procedures were approved by the
institutional animal care and use committee at Canton Zurich in accordance with
the ethical guidelines at University of Zurich, Switzerland.
Rescue experiments in mmut zebraﬁsh. A transgenic line expressing mmut-
mCherry was generated under the control of the liver fatty acid-binding protein
(lfabp or fabp10a) promoter. Primers used to clone lfabp promoter are lfabp-Fwd:
5′-AAATGCAAATTCTGAGCAAATGAC-3′; and lfabp-Rev: 5′-GCTTTCTGGA
GAAGCTCAACA-3′. Primers used for ampliﬁcation of mut cDNA are mut-Fwd:
5′-CCCGATGCCTACATAACAACA-3′; and mut-Rev: 5′-GAACCACCT
GATGGTGAGTGA-3′. Stable zebraﬁsh line expressing mmut-mCherry in the liver
was established and outcrossed with mmut+/del11zebraﬁsh to generate transgenic
mutant line, which was crossed with mmut+/del11zebraﬁsh to produce homozygous
larvae. Ten zebraﬁsh embryos at 5 or 10 dpf were pooled and homogenized by
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14729-8
16 NATURE COMMUNICATIONS |          (2020) 11:970 | https://doi.org/10.1038/s41467-020-14729-8 | www.nature.com/naturecommunications
sonication in solution containing 50% acetonitrile and 10 mM ammoniaformate,
and prepared for methylmalonic acid measurements. Where indicated, zebraﬁsh
larvae were treated at 9 dpf with system water containing DMSO or MitoQ
(200 nM; Focus Biomolecules) for 24 h. The ﬂuorescent signal of reporter protein
mito-Grx1-roGFP2 (as described below) and the larval swimming were analysed at
10 dpf. For larval movement tracking, 10 dpf zebraﬁsh larvae were kept indivi-
dually in ﬁsh system water in a 24-well plate. After 10 min of adaptation, the larvae
swimming tracking is recorded and analysed in live with zebrabox (ViewPoint)
with light stimulation during 5 min. Where indicated, 5-dpf zebraﬁsh were fed with
a low-protein diet (kindly provided by Dr. Carvalho, University of Porto) until to
the sampled day (14 dpf), and the distribution of mmut zebraﬁsh larvae was
assessed. A range of 100‒120 embryos obtained from in-cross strategies between
heterozygous zebraﬁsh were raised to the sampled day, and the percentage of wild
type, heterozygous, and homozygous were determined after genotyping procedure.
Detection of mitochondrial ROS in mmut zebraﬁsh. To measure mitochondrial
ROS in zebraﬁsh larvae, we generated a transgenic line expressing the reporter
protein mito-Grx1-roGFP2 under the control of the liver fatty acid-binding protein
(lfabp) promoter. The plasmid pLPCX-mito-Grx1-roGFP2 was kindly provided
from Dr. Dick (Addgene plasmid # 64977). Plasmid DNA pDestTol2CG2-lfabp::
mito-Grx1-roGFP2 was co-injected with Tol2 transposase mRNA into zebraﬁsh
embryo at one-cell stage. Mosaic larvae expressing lfabp::mito‒Grx1‒roGFP2 were
raised to adulthood and then outcrossed with mmut+/del11 zebraﬁsh to produce
mmut+/del11 zebraﬁsh expressing mito-Grx1-roGFP2 in the liver. The ﬂuor-
escent signal of Grx1-roGFP2 is analysed using light-sheet microscope (Zeiss, Z.1)
after excitation at 405 and 488 nm and detected through the same emission ﬁlter
(505‒545 nm). Imaging settings were maintained with the same parameters for
comparison between different experimental conditions. The acquired data were
processed by Huygens software for deconvolution, and the mean ﬂuorescence
intensities of randomly selected ROIs were measured and expressed as the blue/
green ﬂuorescence intensity ratio.
Mouse models. The mice were maintained under temperature- and humidity-
controlled conditions with 12 h light/12 h dark cycles with free access to appro-
priate standard diet in accordance with the institutional guidelines of National
Institutes of Health Guide for the Care and Use of Laboratory Animals. The mice
bearing ﬂoxed Cox10 (Cox10 ﬂ/ﬂ) alleles, in which the exon 6 is ﬂanked by two loxP
sequences, were kindly provided by Dr. Moraes (Department of Neurology, Uni-
versity of Miami). The mice bearing ﬂoxed Atg7 (Atg7 ﬂ/ﬂ) alleles were kindly
provided by the RIKEN BRC through the National-Bio-Resource Project of the
MEXT, Japan. The mice bearing germline Prkn2 and Pink1 knockout were pur-
chased from Jackson Laboratory. The mice bearing ﬂoxed Mmut (Mmut ﬂ/ﬂ)
alleles, in which the exon 3 is ﬂanked by two loxP sequences, and the mice carrying
M698K point mutation in the Mmut gene was performed by Polygene (Rümlang,
Switzerland) using the C57Bl/6-derived embryonic stem cell targeting. To obtain
Mmut KO/KI mice, females Mmut WT/KO were crossed to Mmut KI/KI males as
previously described29. Mouse genotyping was performed on genomic DNA
extracted from ear punch biopsies using the primers 5′-GTGGGTGTCAGCA-
CACTTG-3′ (forward) and 5′-CGTATGACTGGGATGCCT-3′ (reverse) for the KI
allele and 5′-ACAACTCCTTGTGTAGGTC-3′ (forward) and 5′-CCTTTAG
GATGTCATTCTG-3′ (reverse) for the KO allele. All the mice were maintained on
a C57BL/6 background. Animal care and experimental procedures were approved
by the institutional animal care and use committee at Canton Zurich in accordance
with the ethical guidelines at University of Zurich, Switzerland.
Kidney function. The mice were placed overnight in metabolic cages with ad
libitum access to food and drinking water; urine was collected on ice, body weight,
water intake, and diuresis were measured46. Blood (from sublingual vein) was
obtained after anaesthesia with ketamine/xylazine or isoﬂurane. Urea and creati-
nine were measured using UniCel DxC 800 pro Synchron (Beckman Coulter,
Fullerton, CA, USA). The creatinine clearance was calculated using the equation
Urine(creatinine) × Diuresis/Plasma(creatinine). Plasma and urinary levels of Lcn2 were
measured by using an enzyme-linked immunosorbent assay in according to the
manufacturer’s instructions (EMLCN2, Thermo Fischer Scientiﬁc, Waltham, MA).
Picro Sirius Red staining. Picro Sirius Red (ab150681, Abcam) staining was
performed on 5-μm-thick parafﬁn sections from kidneys of MmutWT/KI and
MmutKO/KI. Brieﬂy, the sections were deparafﬁnized, rehydrated and subsequently
incubated with Picro Sirius Red for 1 h at room temperature. Sections were then
washed twice in acidiﬁed water (0.05% acetic acid in distilled water), dehydrated
and mounted. Images were acquired with a ZEISS AxioScan.Z1 slide scanner
(ZEISS).
Primary cultures of mouse proximal tubular cells. The kidneys were harvested
from Mmut WT/KI and Mmut KI/KO or from Mmut ﬂ/ﬂ or Atg7 ﬂ/ﬂ or Cox10 ﬂ/ﬂ,
and from Pink1 or Prkn2 KO and from their corresponding control littermates: one
kidney was split transversally, and one half was ﬁxed and processed for immu-
nostaining while the other half was ﬂash-frozen, homogenized by Dounce homo-
genizer in 1 mL of RIPA buffer that contains protease and phosphatase inhibitors
and processed for western blot analysis46. The contralateral kidney was taken to
generate primary cultures of mPTCs46. Freshly micro-dissected PT segments were
seeded onto collagen-coated chamber slides (81156, ibidi) and/or collagen-coated
6- or 24-well plates (145380 or 142475, Thermo-Fisher Scientiﬁc), and cultured at
37 °C and 5% CO2 in DMEM/F12 (21041-025, Thermo-Fisher Scientiﬁc) with 0.5%
dialyzed fetal bovine serum (FBS), 15 mM HEPES (H0887, Sigma Aldrich),
0.55 mM sodium pyruvate (P2256, Sigma Aldrich), 0.1 mL L−1 non-essential
amino acids (M7145, Sigma Aldrich), hydrocortisone, human EGF, epinephrine,
insulin, triiodothyronine, TF, and gentamicin/amphotericin (Single Quots® kit,
CC-4127, Lonza), pH 7.40, 325 mOsm kg-1. The medium was replaced every 48 h.
Conﬂuent monolayers of mPTCs were expanded from the tubular fragments after
6–7 days, characterized by a high endocytic uptake capacity. These cells were
negative tested for mycoplasma contamination. All experiments were performed on
conﬂuent monolayers grown on chamber slides or 24-well or 6-well tissue culture
plates. Where indicated, the mitochondrial damage and mitophagy were triggered
by treating primary cultures of PT cells with Rotenone (5 μM in the fresh culture
medium for the indicated time) Oligomycin A and Antimycin (4 and 0.8 μM,
respectively, in the fresh culture medium for the indicated time). Afterwards, the
cells were processed and analysed as described below.
Adenovirus transduction. For RNA interference studies, the adenovirus con-
structs include scrambled short hairpin (Scmb-shRNA) or shRNAs encoding
individually mouse Atg7. For expression studies, adenovirus constructs used
include CMV (control vector, Ad-CMV-GFP, Vector Biolabs) or an individually
carrying Cre-recombinase (Ad-Cre-GFP, Vector Biolabs) or carrying human
hemagglutinin (HA)-tagged PINK1, or carrying mouse green ﬂuorescence protein
(GFP)-taggedMap1lc3b or expressing green ﬂuorescent protein (GFP) or the coral-
derived protein Keima with the mitochondrially targeting sequence of the human
cytochrome C oxidase subunit VIII (COXVIII). All adenovirus constructs were
purchased from Vector Biolabs (University City Science Center, Philadelphia,
USA). The cells were plated onto collagen-coated chamber slides or 24- or 6-well
tissue culture plates. Adenovirus transduction was performed 24 h after plating
when the cells reached approximately 70–80% conﬂuence. The cells were subse-
quently incubated for 16 h at 37 °C with culture containing the virus at the con-
centration (0.2125 × 109 PFU mL−1). The cells were afterwards challenged with
fresh culture medium every 2 days, cultured for 5 days (unless otherwise speciﬁed)
and collected for analyses.
Microarray and drug–disease network modelling. The Affymetrix Gene-Chip
(HG-U113A) hybridization experiments were performed in triplicate at the Coriell
Genotyping and Microarray Center, Coriell Institute for Medical Research, Cam-
den, New Jersey, USA, on total RNA extracted from tubular cells derived from
three healthy donors and three muto MMA patients (Supplementary Table 1;
ref. 25). To identify downstream transcriptional effects of loss-of-MMUT function,
microarray data were pre–processed using the Bioconductor package Affy52 and
normalized with the RMA method65. Differentially expressed (DE) genes between
conditions (MMA patient-derived versus their control cells) were identiﬁed using a
Bayesian t-test66. For each P value, the Benjamin–Hochberg procedure was used to
calculate the false discovery rate (FDR) to avoid the problem of multiple testing.
Mode of Action by Network Analysis (Mantra 2.0, http://mantra.tigem.it) and
Drug Set Enrichment Analysis (DSEA, http://dsea.tigem.it) were employed to
predict either effective therapeutics or druggable biological processes in MMA
patient-derived kidney cells. Taking advantage of the connectivity map data set —
which includes transcriptional proﬁles following treatment of 1309 small molecules
across ﬁve different cell lines—Mantra aims to identify compounds tran-
scriptionally similar or different to a disease proﬁle just providing as input the
ranked list of genes sorted according to their differential expression. This analysis
enabled us to capture the top-ranked small bioactive molecules that tran-
scriptionally reverse the MMA gene signature molecular pathways consistently up-
or downregulated by these set of drugs were then detected using DSEA.
Reverse transcription-quantitative PCR. Total RNA was extracted from mouse
tissues using Aurum TM Total RNA Fatty and Fibrous Tissue Kit (Bio-Rad, Her-
cules, CA). DNAse I treatment was performed to eliminate genomic DNA con-
tamination. Total RNA was extracted from cell cultures with RNAqueousR kit
(Applied Biosystems, Life Technologies). One microgram of RNA was used to
perform the reverse transcriptase reaction with iScript TM cDNA Synthesis Kit
(Bio-Rad). Changes in mRNA levels of the target genes were determined by relative
RT–qPCR with a CFX96TM Real-Time PCR Detection System (Bio-Rad) using iQ
TM SYBR Green Supermix (Bio-Rad). The analyses were performed in duplicate
with 100 nM of both sense and anti-sense primers in a ﬁnal volume of 20 µL using
iQTM SYBR Green Supermix (Bio-Rad). Speciﬁc primers were designed using
Primer3 (Supplementary Tables 2–4). PCR conditions were 95 °C for 3 min fol-
lowed by 40 cycles of 15 sec at 95 °C, 30 s at 60 °C. The PCR products were
sequenced with the BigDye terminator kit (PerkinElmer Applied Biosystems) using
ABI3100 capillary sequencer (PerkinElmer Applied Biosystems). The efﬁciency of
each set of primers was determined by dilution curves (Supplementary Tables 2–4).
The program geNorm version 3.4 was applied to characterize the expression sta-
bility of the candidate reference genes in kidneys and six reference genes were
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selected to calculate the normalization factor. The relative changes in targeted
genes over Gapdh mRNAs were calculated using the 2−ΔΔCt formula. For the
absolute quantiﬁcation of mitochondrial:nuclear DNA ratio, relative values for
ND1 and ACTB (in human cells) or for Nd1 and Hbb (in murine cells) were
compared within each sample to generate a ratio representing the relative level of
mitochondrial DNA per nuclear genome. Primers used for mitochondrial DNA:
nuclear DNA ratio in human cells are ND1-Fwd: 5′-ACACTAGCAGA
GACCAACCG-3′ and ND1-Rev: 5′-GAAGAATAGGGCGAAGGGGC-3′; ACTB-
Fwd: 5′-TCACCCACACTGTGCCCATCTACGA-3′ and ACTB-Rev: 5′-CAGCG
GAACCGCTCATTGCCAATGG-3′. Primers used for mitochondrial DNA:nuclear
DNA ratio in murine cells are Nd1-Fwd: 5′-TAGAACGCAAAATCTTAGGG-3′
and Nd1-Rev: 5′-TGCTAGTGTGAGTGATAGGG-3′; Hbb-Fwd: 5′-AGGCA
GAGGCAGGCAGAT-3′ and Hbb-Rev: 5′-GGCGGGAGGTTTGAGACA-3′.
Lysosome-based cellular degradation. The detection of lysosomal activity was
performed in live in kidney cells by using Bodipy-FL-Pepstatin A (P12271, Thermo
Fischer Scientiﬁc) according to the manufacturer’s speciﬁcations. The cells were
pulsed with 1 μM Bodipy-FL-Pepstatin A in Live Cell Imaging medium (A14291DJ,
Thermo Fischer Scientiﬁc) for 1 h at 37 °C, ﬁxed, and subsequently analysed by
confocal microscopy46. The numbers of PepA-positive structures per cell were
quantiﬁed by using the open-source cell image analysis software CellProﬁlerTM as
described below.
Mitochondrial membrane potential. The mitochondrial membrane potential
(Δψ) was measured in accordance with the manufacturer’s speciﬁcations. The cells
were pulsed with 50 nM tetramethylrhodamine methyl ester perchlorate (TMRM,
T668 Thermo-Fisher Scientiﬁc) and 1 μM MitoTracker Red FM (Invitrogen,
M22426) for 30 min in live cell imaging at 37 °C. After washing, the cells were
subsequently analysed by confocal microscopy46 in a chamber heated to 37 °C at
5% CO2. Images were acquired using Leica SP8 confocal laser scanning microscope
(Center for Microscopy and Image Analysis, University of Zurich) and the ﬂuor-
escence intensity was quantiﬁed by the open source image processing Fiji (which is
just ImageJ, NIH) as described below.
Detection of mitochondrial ROS. The cells were pulsed with 2.5 μM MitoSOX
Red Mitochondrial Superoxide Indicator (M36008, Thermo-Fisher Scientiﬁc) and
1 μMMitoTracker Green FM (Invitrogen, M7514) for 30 min in live cell imaging at
37 °C. After washing, the cells were subsequently analysed by confocal microscopy
in a chamber heated to 37 °C at 5% CO2. Images were acquired using a Leica SP8
confocal laser scanning microscope (Center for Microscopy and Image Analysis,
University of Zurich) and the ﬂuorescence intensity was quantiﬁed by the open
source image processing Fiji (which is just ImageJ, NIH) as described below.
mt-Keima-based mitophagy assay. Cells expressing mt-Keima were treated in
the presence and in the absence of mitochondrial complex I inhibitor Rotenone or
electron transport chain inhibitors Oligomycin A and Antimycin as previously
described and analysed by confocal microscopy in a chamber heated to 37 °C at 5%
CO2. mt-Keima protein was excited both at 458 nm (neutral, pseudo-coloured in
green) and 561 nm (acidic, pseudo-coloured in red) and detected through the same
emission ﬁlter (570‒695 nm). Laser power was set up at the lowest output which
would enable the clear visualization of the mt-Keima signal, and were individua-
lized for each experimental condition. Imaging settings were maintained with the
same parameters for comparison between different experimental conditions.
Images were acquired using a Leica SP8 confocal laser scanning microscope
(Center for Microscopy and Image Analysis, University of Zurich) and the ﬂuor-
escence intensity was quantiﬁed by the open source image processing software Fiji
(ImageJ, NIH) as described below.
Measurement of oxygen consumption rate and metabolic proﬁling. OCR in
mouse or human kidney tubule cells and in zebraﬁsh larvae was measured with
XFp Extracellular Flux Analyzers (Agilent Seahorse Biosciences). The cells were
incubated with XF-Base Medium (non-buffered RPMI 1640 containing either
2 mM L-glutamine, 1 mM sodium pyruvate, and 10 mM glucose, pH 7.4). Three
measurements were assessed under basal conditions and upon addition of 2 μM
Oligomycin (Oligo), 0.5 μM FCCP, and 1 μM Rotenone (ROT)/Antimycin A
(ANT). All the reagents were provided by XFp Cell Mito Stress Test Kit (Agilent
Seahorse Biosciences). OCR measurements were normalized to the numbers of
cells (TC10TM automated cell counter, Bio-Rad). The zebraﬁsh larvae were
anaesthetised with 125 mg/L of MS222 and placed individually into the wells of a
24-wells microplate, ﬁlled with 500 mL of E3 media (pH 7.4) containing anaes-
thesia solution MS222 and covered by capture screens. After incubation in a non-
CO2 incubator at 28.5 °C for 20 min, the metabolic measurements were analysed in
live. One measurement cycle consisted of a brief wait period to acclimate the plate,
2 min mix, 1 min wait, and 2 min data acquisition. Eight measurement cycles were
performed to establish the average value.
Detection of Ptd-Ins3P. Ptd-Ins3P staining was performed according to pre-
viously established protocols67. Brieﬂy, the cells were ﬁxed for 15 min in 2% PFA
and permeabilized for 5 min with 20 μM digitonin in buffer A (150 mM NaCl,
20 mM HEPES, pH 7.4, and 2 mM EDTA). Cells were subsequently incubated for
45 min with buffer A supplemented with 5% goat serum and mCherry-2× FYVE
Ptd-Ins3P-binding domain and immunostained with the anti-RFP antibody to
amplify the detection of mCherry probe. The cells were washed and post-ﬁxed with
2% PFA for 5 min, and analysed by confocal microscopy and quantiﬁed by using
the open-source cell image analysis software CellProﬁlerTM as described below.
Immunoﬂuorescence and confocal microscopy. Fresh mouse kidneys were ﬁxed
by perfusion with 50–60 mL of 4% paraformaldehyde in PBS (158127, Sigma
Aldrich), dehydrated and embedded in parafﬁn at 58 C. Parafﬁn blocks were
sectioned into consecutive 5-μm-thick slices with a Leica RM2255 rotary micro-
tome (Thermo-Fisher Scientiﬁc) on Superfrost Plus glass slides (Thermo-Fisher
Scientiﬁc). Before staining, slides were deparafﬁnized in changes of CitriSolv (22-
143-975, Thermo-Fisher Scientiﬁc) and 70% isopropanol. Antigen retrieval was
accomplished by heating the slides at 95 °C for 10 min in 10 mM sodium citrate
buffer (pH 6.0). The slides were quenched with 50 mM NH4Cl, blocked with 3%
BSA in PBS Ca/Mg (D1283, Sigma Aldrich) for 30 min and stained with primary
antibodies speciﬁc for Mutase, UMOD, AQP2, CD3, Ly6G diluted in blocking
buffer overnight at 4 °C. After two washes in 0.1% Tween 20 (v/v in PBS), the slides
were incubated with the corresponding ﬂuorophore-conjugated Alexa secondary
antibodies (Invitrogen) diluted in blocking buffer at room temperature for 1 h and
counterstained with 1 μg Biotinylated Lotus Tetragonolobus Lectin (LTL; B-1325
Vector Laboratories) and 1 µM DAPI (D1306, Thermo Fischer Scientiﬁc). The
slides were mounted in Prolong Gold Anti-fade reagent (P36930, Thermo Fisher
Scientiﬁc) and analysed by confocal microscopy. The images were acquired using a
Leica SP8 confocal laser scanning microscope (Center for Microscopy and Image
Analysis, University of Zurich) equipped with a Leica APO ×63 NA 1.4 oil
immersion objective at a deﬁnition of 1024 × 1024 pixels (average of 8 or 16 scans),
adjusting the pinhole diameter to 1 Airy unit for each emission channel to have all
of the intensity values between 1 and 254 (linear range). The micrographs were
processed with Adobe Photoshop (version CS5, Adobe System Inc., San Jose, USA)
software. Quantitative image analysis was performed by selecting randomly ∼5‒10
visual ﬁelds per each slide that included at least 3‒5 PTs (LTL positive), using the
same setting parameters (i.e., pinhole, laser power, and offset gain and detector
ampliﬁcation below pixel saturation). The numbers of CD3 or Ly6G-positive
structures per ﬁeld were manually counted.
The cells were ﬁxed for 10 min with 4% PFA in PBS, quenched with 50 mM
NH4Cl and permeabilized for 20 min in blocking buffer solution containing 0.1%
Triton X-100 and 0.5% BSA dissolved in PBS. Subsequently, cells were incubated
overnight with the appropriate primary antibodies at 4 °C. After repeated washing
with PBS, the slides were incubated for 45 min with the suitable ﬂuorophore-
conjugated Alexa secondary antibodies (Invitrogen), counterstained with 1 µM
DAPI for 5 min, mounted with the Prolong Gold Anti-fade reagent and analysed
by a Leica SP8 confocal laser scanning microscope (Center for Microscopy and
Image Analysis, University of Zurich) using the settings described above.
Quantitative image analysis was performed by selecting randomly ﬁve visual ﬁelds
pooled from biological triplicates, with each ﬁeld including at least 10–15 cells,
using the same setting parameters (i.e. pinhole, laser power, and offset gain and
detector ampliﬁcation below pixel saturation). The quantitative cell image analyses
of mitochondrial morphology68 were performed using mitochondrial morphology
plug in of the open-source cell image software Fiji. The quantitative cell image of
mitochondrial membrane potential, production of mitochondrial ROS and mt-
Keima red/green signal, the analyses of ﬂuorescence were performed following
background subtraction over cellular regions of interests (ROIs) and quantiﬁed
using the multi-measure plugin of Fiji. Mean ﬂuorescence intensity ratios of
selected ROIs matching cells were determined and expressed as TMRM/
MitoTracker, MitoSOX and mt-Keima red/green ratios, respectively. The
quantitative cell image analyses of subcellular structures were determined by using
the open-source cell image analysis software CellProﬁlerTM69. In particular, the
speciﬁc module “Measure-Object-Intensity-Distribution” was used to score the
number of ATP5B, PtdIns-3P, ATG13, WIPI2, Parkin, LC3, and PMP70 or Pep-A+
structures. The pipeline “Cell/particle counting and scoring the percentage of
stained objects” was used to score either the fractions of Lamp1-positive structures
(or mito-GFP positive) that were also positive for LC3 (or Parkin). The number of
cells and/or ﬁelds of views for analysis for each condition and the number of the
independent experiments are indicated in the ﬁgure legends accordingly.
Electron microscopy. Animal tissue samples and cultured cells were ﬁxed in 2.5%
glutaraldehyde in 100 mM sodium cacodylate, at pH= 7.43 for 1 h at room tem-
perature, post-ﬁxed in 1% osmium tetroxide, 1.5% potassium ferrocyanide in 0.1 M
cacodylate for 1 h on ice. After washing in distilled water, the samples were stained
with 0.5% uranyl acetate in water overnight at 4 °C. The samples were ﬁnally
dehydrated in a graded ethanol series, embedded in Epon 812 and ﬁnally cured at
60 °C for 48 h. Ultrathin (70‒90 nm) sections were cut using a Leica Ultracut UCT
ultramicrotome and collected on copper grids, stained with uranyl acetate and
Sato’s lead citrate before been imaged with a FEI Talos 120 kV transmission
electron microscope (FEI Company, Netherlands) and images were acquired by a
4k × 4K Ceta CMOS camera. AVs were identiﬁed and categorized as autophago-
somes or autolysosomes according to conventional criteria31. Autophagosome
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should have a double membrane (completely or partially visible), absence of
ribosomes in the outer membrane, luminal density comparable to the surrounding
cytosol and identiﬁable organelles or regions of organelles in their lumen; autop-
hagolysosomes should have single membrane, luminal density lower than sur-
rounding cytosol with luminal material partially recognizable as speciﬁc organelles
or heterogeneous amorphous material. Primary and secondary lysosomes were
excluded from the quantiﬁcation. The term autophagic vacuole was used for
identifying both autophagosomes and autophagolysosomes structures. At least 20
random selected cellular proﬁles were acquired and analysed using ImageJ soft-
ware. For the quantiﬁcation of content of AVs, the percentage of cytosolic area
occupied by AVs was calculated. For the quantiﬁcation of the morphology of
mitochondrial network, the cross-sectional area (A) and perimeter (P) derived
from each mitochondrion was measured and circularity (c) was calculated
according to the formula circularity= 4π (area/perimeter2).
Correlative light electron microscopy. The cells were grown on ﬁnder grids and
prepared for confocal microscopy analyses. Z-stacks of cells of interest were taken
with the PerkinElmer Ultra View ERS confocal microscope. The coordinates of the
cells on the ﬁnder grid were determined by bright-ﬁeld microscopy. Cells were
ﬁxed in 1% glutaraldehyde in 0.1 M cacodylate buffer (Sigma) and post-ﬁxed with
1.5% potassium ferricyanide, 1% OsO4 in 0.1 M cacodylate buffer. Cells were
stained overnight with 0.5% uranyl acetate, dehydrated in ethanol, and embedded
in epon. After baking for 48 h at 60 °C, the resin was released from the glass
coverslip by temperature shock in liquid nitrogen. Serial sections (70–90 nm) were
collected on carbon-coated formvar slot grids and imaged with a FEI Talos 120 kV
transmission electron microscope (FEI Company, Netherlands) and images were
acquired by a 4k × 4K Ceta CMOS camera. LM and EM images were aligned using
Ec-CLEM Icy plugin and overlaid using Photoshop software.
Soluble and insoluble fractionation. The cells were lysed in buffer containing
50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 1% Triton X-100, 1% sodium
deoxycholate supplemented with protease (1836153001, Roche) and phosphatase
inhibitors (04906845001, PhosSTOP Sigma), and centrifuged at 16,000g at 4 °C for
20 min to collect the soluble fraction (supernatant). The pellet was suspended in a
buffer containing 4% SDS and 20 mM HEPES, pH 7.5, protease and phosphatase
inhibitors, and further centrifuged at 18,000 g at room temperature for 10 min to
collect the insoluble fraction (supernatant). The samples were boiled at 95 °C for
5 min and analysed by western blotting.
Immunoblotting. Proteins were extracted from mouse tissues or cultured cells,
lysed using a buffer which contains protease (1836153001, Roche) and phosphatase
inhibitors (04906845001, PhosSTOP Roche), followed by sonication and cen-
trifugation at 16,000g for 10 min at 4 °C. The samples were thawed on ice, nor-
malized for protein (20 μg per lane), dissolved in Laemmli sample buffer and
separated by SDS-PAGE under reducing conditions. After blotting onto PVDF and
blocking with 5% non-fat milk (1706404, Bio-Rad Laboratories), the membranes
were incubated overnight at 4 °C with primary antibody, washed, incubated with
peroxidase-labelled secondary antibody and visualized with enhanced chemilu-
minescence (WBKLS0050, Millipore, Sigma). Signal intensity was assessed by
measuring the relative density of each band normalized to β-actin, GAPDH or α-
tubulin with ImageJ software.
Cell viability assay. Cell viability was determined by the Cell Counting Kit-8
(CCK-8) assay (Dojindo, Rockville, USA). Cells were seeded at a density of
5000 cells/well of 96-well plates and grown until they reached 90% conﬂuence. The
cell medium was replaced by water-soluble tetrazolium salt solution and incubated
for 30 min at 37 °C according to the manufacturer’s protocol. The amount of
formazan dye generated by dehydrogenase activity was measured at 450 nm in a
TECAN inﬁnite 200 reader (Männedorf, Switzerland) according to the manu-
facturer’s speciﬁcations.
Cell proliferation. To measure cell proliferation, the cells were seeded in 24-well
plates at a density of 2.0 × 104 cells per well. The cells were cultured for 2 days and
cell medium was renewed daily. Where indicated, the cells were treated with
Rotenone (24 h at the indicated concentrations), then trypsinized every 24 h and
quantiﬁed using the Countess automated cell counter TC10 automated cell counter
(Bio-Rad). The time-course experiments were repeated three times.
Statistics and reproducibility. The plotted data were presented as mean ± stan-
dard error of the mean (SEM). Statistical comparisons between experimental
groups were determined by using one-way analysis of variance (ANOVA) followed
by a Bonferroni or Dunnet post hoc test, when appropriate. When only two groups
were compared, two-tailed unpaired or paired Student’s t-tests were used as
appropriate. The normality criteria (calculated by D’Agostino and Pearson omni-
bus normally test) were met. Non-parametric data were analysed using a
Kruskal–Wallis test with Dunn’s multiple comparison correction. Statistical com-
parisons between untreated and MitoQ-treated mmut zebraﬁsh in Fig. 9c was
determined by chi-square goodness of ﬁt test. The levels of statistical signiﬁcance
are indicated by symbols, and the P values are indicated in the ﬁgure legends along
with the statistical tests. All experiments reported here were performed at least two
to three times independently, unless otherwise indicated in the ﬁgure legends.
Experiments in Fig. 9c were performed once. The investigators were not blinded to
allocation during the experiments and outcome assessment. GraphPad Prism
software v. 7.0a (GraphPad software) was used for generating all statistical analyses.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The microarray data that support the ﬁndings of this study are provided in the
Supplementary Data 1 and deposited in NCBI Gene Expression Omnibus (GEO), under
the accession number GSE120683. The Source data underlying Fig. 1a–b, 1d, 1e, 1g, 2a–g,
3a–g, 4a–f, 5a–f, 6b–h, 7b–h, 8b–g, 9a–d, and Supplementary Figs 1a–c, 1f, 1i, 2a–e, 3a,
3c–j, 3l–m, 4c, 4e, 4g, 5b–f, 6a–b,7b, 7d–e, 7g–h, 8c–j, 9d–e, 10b, 11a–d are provided in
the Source Data ﬁle. Additional data and/or reagents that support the ﬁndings of this
study are available from corresponding authors, A.L. and O.D, upon reasonable request.
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